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Chapter 1 Introduction to Quantification of 








Cardiovascular imaging has long played an important role in the clinical diagnosis and prediction of 
prognosis in patients with suspected or known cardiovascular disease and was traditionally performed 
using plain film X-ray, cardiac catheterization, nuclear imaging and cardiac ultrasound. [1] In the past 
decades, cardiovascular computed tomography (CT) has emerged as non-invasive modality to evaluate 
cardiovascular disease at anatomical as well as functional level. 
Rapid technological advances have rendered CT coronary angiography an accurate and reliable imaging 
modality to assess coronary anatomy, coronary artery disease (CAD) and evaluation of bypass grafts [2]. 
Multi-detector CT (MDCT) has also shown its ability to provide left ventricular (LV) functional 
parameters with retrospective ECG-gating because of increased temporal resolution. In addition, CT 
techniques to assess myocardial perfusion and valve function are also gaining ground.  
As a result of these fast developments in scanners and scanning techniques, the amount of data acquired 
using CT is high and still increasing. Therefore, to allow adequate evaluation of these datasets, post-
processing using advanced visualization tools is required. These tools range from different types of 
visualization to semi-automatic and automatic segmentation of structures of interest. However, there is a 
wide variety in tools available and it can therefore be difficult to determine the right post-processing 
tools for the task at hand. Furthermore, the interpretation of the results of post-processing, especially 
when using (semi-)automatic tools, should be handled with care. In short, different post-processing 
procedures should be used for the different clinical questions that are the indication for cardiac 
examination using CT.  
Common visualization techniques are orthogonal review, curved Multi Planar Reformation (MPR), 
sliding-thin-slice Maximum Intensity Projection (sts-MIP), and Volume Rendering (VR) which are 
mostly used in various combinations and are supplemented by advanced tools for (semi-) automatic 
segmentation and measurement. 
A cardiac dataset consists of multiple, successive axial slices, which together form a volume. MPRs can 
be reconstructed from this dataset and can show the scanned structures in a different plane, other than 
the acquired axial plane, like coronal, sagittal or oblique planes. For example, most dedicated cardiac 
CT software packages display a cardiac CT dataset automatically in axial, sagittal and coronal view, 






often complemented by a three-dimensional (3D) view. By turning the projection lines manually, an 
oblique or double oblique MPR can be obtained.  
MIP is a specific type of visualization in which only the voxels with the highest intensities are projected 
into a 2D image [3]. In case of the sts-MIP a small slab is extracted from the datasets, in most cases 
based on a plane defined using MPR, to apply the MIP algorithm to. 
The volume rendering technique transforms the acquired volume data into 3D projection images [3]. 
Volume rendering provides ‘real’ depth cues and allows the user to assign properties such as color, 
transparency, reflection, etc. to each possible voxel value. Although 3D volume rendering was quite 
time-consuming in earlier years, nowadays software tools provide automatic 3D images when a 
complete cardiac CT dataset is loaded within seconds. Moreover, most software packages are capable of 
automatically segmenting the heart from the surrounding structures.  
Volume rendering has been the most commonly used 3D reconstruction technique in the clinical 
practice. However recently a novel rendering 3D rendering technique called Cinematic Rendering has 
been introduced [4]. This technique follows the same steps to determine the color and opacity as volume 
rendering does. The difference is that instead of ray-casting that volume rendering is based on cinematic 
rendering is based on path-tracing methods and the global illumination model. The algorithm simulates 
different paths of photons coming from different directions through a volumetric dataset and their 
interaction with the volume to create one pixel. The technique models real life like propagation of the 
light to create realistic 3D images based on the medical image data [5-6].  
Thanks to the developments in 3D reconstruction and the segmentation techniques, CT becomes an 
important imaging modality in the diagnosis and treatment of the cardiovascular diseases. CAD and 
valvular diseases are two of the major cardiovascular disease groups that benefit from these 
developments. In the scope of this thesis, original researches and the literature reviews related to 
diagnosis and treatment of these cardiovascular disease groups are presented. In the following 
paragraphs, you will find further information of using CT in the therapeutic management of coronary 








Use of Cardiovascular Computed Tomography in Therapeutic management of Coronary Artery 
Disease 
Worldwide, coronary artery disease is the leading cause of death, with yearly over 17 million deaths 
[1,7]. Currently, the evaluation of CAD is mainly the field of CT. To evaluate coronary artery disease, 
two approaches can be followed. The first approach is the evaluation of the coronary lumen, for stenosis 
measurement. The second approach is the evaluation of the coronary wall, for either coronary 
calcification quantification or plaque morphology analysis. These two different approaches have their 
own requirements on the post-processing used. 
Coronary Stenosis Measurement 
Currently, the automatic segmentation of the coronary artery tree resulting in a display composed of 
curved multiplanar reformations along the centerline of the coronary arteries and orthogonal cross-
sections is commonplace [8] and clinical implementation of advanced visualization is included in 
current guidelines [9]. Reporting high sensitivity (89%) and specificity (100%), Busch et al [10] 
concluded that software supported CT-QCA enables automatic quantitative analysis of significant 
coronary artery stenoses with area stenosis greater than 75%. In many cases, the software will also 
identify the correct annotation of the coronary artery tree and will label the RCA, LCA and LCX 
branches automatically provided that the patient has a normal configuration of the coronary artery tree. 
Maurer et al [11] showed in a survey that the vast majority of hospitals performing cardiac imaging 
using CT use these automatically generated curved MPRs for their interpretation.  
However, reliability of the results of these automatically generated curved MPRs heavily depends on the 
algorithm used to extract the centerline of the artery and the amount of user interaction required for the 
segmentation [12]. Furthermore, Dikkers et al [13] showed in a phantom study that manual stenosis 
measurements are significantly more accurate than automatic measurements, indicating that manual 
adjustments are still essential for the non-invasive assessment of coronary artery stenosis. A more 
general approach promoted by other authors is to use axial MDCT images in combination with the 
(automatic generated) multiplanar reconstructions [14]. Ferencik et al [15] tested various image 
processing methods to determine hemodynamically significant stenoses of the coronary arteries and 
found various accuracy levels ranging from 73% to 91%. Based on their results, they stated that the 
evaluation of multidetector CT coronary angiography with interactive image display methods, especially 






interactive oblique MPRs, permits higher diagnostic accuracy than evaluation of pre-rendered images 
(curved MPR, curved MIP, or VRT images). 
The use of multiple techniques in addition to the axial slices in an interactive fashion is supported by the 
majority of reported studies. The evaluation of multidetector CT coronary angiograms for the detection 
of coronary stenosis is frequently reported to be performed interactively on off-line workstations, by 
using a combination of transverse, MPR, MIP, and 3D VRT images [14,16-23]. Some authors evaluated 
multidetector CT data sets initially by using MIP images or a pre-rendered slab of MPR images, and the 
findings were then confirmed by using MPR, curved MPR, or 3D VRT images [24-26]. 
Regardless of the visualization technique used, careful steps must be taken to avoid the effect of motion 
artifacts, as they can lead to false stenoses [27] (Figure 1). By retrospectively checking any plane 
parallel to the z-axis motion artifacts can be detected.  
 
Figure 1: Example where a (significant) stenosis occured at the same z-location as motion artefacts (white 








The amount of coronary calcification is considered to be a strong predictor of coronary events. [28]. 
European guidelines consider CT based coronary artery calcium score as class 2b “may be considered” 
level of evidence. The calcium score is considered as an indicator of the CAD [29]. 
Assessment of coronary calcification is performed on non-contrast-enhanced CT scans usually with a 
relatively large slice thickness of 3mm. From the standard axial views of the heart, with high density 
structures which exceed certain threshold already marked by the software, coronary calcification can be 
manually selected and assigned to a vessel. The most commonly used threshold for the determination of 
coronary calcification is 130 Hounsfield Unit (HU) [30].  
Subsequently, the selected calcifications are automatically quantified based on the generally accepted 
scoring methods (Agatston, Volume or MASS).  
However, the practical use of calcium scoring in serial studies for tracking the progression of disease is 
still hampered by the limited reproducibility of the calcium scores currently in use both because of 
technical [31] and software issues [32]. A study by Groen et al, proposed a way to reduce the 
susceptibility of calcium scoring to cardiac motion by adjusting the calcification threshold according to 
its maximum HU value, promoting an increase of accuracy of at least 10%. [33]. 
Analysis of Plaque Morphology. 
It is reported that, to analyze plaque morphology, multiplanar reconstructions orthogonal to the 
centerline of the (automatically segmented) coronary artery can be obtained resulting in a large number 
of cross-sections of the coronary artery for evaluation of stenotic and nonstenotic coronary 
atherosclerotic lesions [34]. The conventional way of analyzing plaque morphology is by manual visual 
evaluation. To assess maximum luminal narrowing, the optimal image display setting can be chosen on 
an individual basis, in general at a window between 600 and 900 HU and at a level between 40 and 250 
HU. Structures with densities above the adjacent vessel lumen are usually defined as calcified, and 
structures with densities below the vessel contrast as non-calcified plaques [35-36]. Manual 
segmentation of outer vessel wall can also be done for assessment of vessel re-modeling, as this 
parameter plays important role in determining plaque vulnerability [37]. The plaque composition can be 
determined by the mean HU value of manually placed regions of interest (ROI) at different areas inside 






the vessel wall. Of these ROIs, the mean HU value and standard deviation are then used to determine the 
plaque composition.  
Currently, many software packages also provide an automatic determination of lumen and vessel borders 
in combination with color coding of certain ranges of HU values (Figure 2). These ranges should then 
indicate the different types of plaque and result in an automatic determination of the volumetric 
measurement of each plaque type. Therefore, using this automated tool, a complete volumetric analysis 




Figure 2: Automatic plaque morphology assessment. Box pointed by arrow 1 show the area and diameter stenosis 
grade at the most stenotic site, while boxes pointed by arrow 2 and 3 show plaque morphology at the most 
stenotic plaque cross-section and for the whole plaque volume, respectively. 
However, careful selection of the HU ranges should be made as various claims are made by different 







the gold standard [36,38-39]. For example, Leber et al [39] reported MDCT-derived density 
measurements within coronary lesions of 49HU+/-22 for hypoechoic, 91 HU+/-22 for hyperechoic and 
391 HU+/-156 for calcified plaques, while Carrascosa et al [40] reported 71.5HU+/-32.1 for soft and 
116.3HU+/-35.7 for fibrous, and 383.63HU+/-186.1 for calcified plaques. They both reported these 
values to be significantly different.  
Based on current reports, classification of coronary plaque into calcified and non-calcified plaque could 
be feasible, either by qualitative visual assessment, using a common threshold for calcification, or even 
using automatic vessel segmentation tools [41-42]. However, sub classification between the different 
non-calcified plaque types, such as lipid and fibrous plaque, seems difficult because of the variety in 
reported cut-off values and the overlap in HU ranges. Furthermore, various factors, such as the 
reconstruction kernel and the attenuation level of the contrast enhanced blood in the arteries, have been 
reported to significantly influence the HU value of plaques used for the determination of plaque 
composition [43-44]. 
Use of Cardiovascular Computed Tomography in Therapeutic management of Aortic Stenosis 
Cardiac diseases are the most common cause of death in developed countries, and Aortic valve stenosis 
(AS) is the most common valvular heart disease in the population older than 65 years [45]. In AS the 
aortic valve becomes narrower which affects the blood flow from the heart into the aorta. Visualization 
of the aortic valvular area (AVA) is required to obtain preoperative knowledge.  
Various non-invasive imaging modalities are available to assess function and morphology of the cardiac 
valves [46] of which echocardiography is widely used due to low costs and wide availability. 
However, due to fast technical developments of CT and Magnetic Resonance Imaging (MRI), these 
imaging modalities are gaining ground in the evaluation of the cardiac valves [47]. Studies show that the 
planimetric measurements of AVA by Dual-Source CT (DSCT) are very well correlated with the 
measurements done by Transthoracic Echocardiography (TTE). Besides DSCT has higher 
reproducibility compared with TEE [48]. However, CT requires comparatively high radiation dose 
because a dedicated scan has to be made with retrospective gating and optimal image quality throughout 
the cardiac cycle. Advantages of MRI compared to CT are lack of radiation exposure and superior 
temporal resolution. In addition, with MRI no intravenous contrast administration is required because of 
the excellent contrast between the blood pool and low-signal-intensity myocardial wall and valves. MRI 






also provides the ability for quantitative measurements and the possibility to add valvular velocity flow 
mapping measurements [49]. Valvular function is assessed with SSFP cine MRI [46]. In case of a valve 
insufficiency or stenosis, a void (jet) can be visually observed due to turbulent flow.  
Manghat et al. [49] provide a manual protocol for the optimal CT imaging planes of the heart valves and 
chambers using MPR and multiphasic cine movie loops based on the standard echocardiographic 
imaging planes. With contrast enhanced MDCT, the number of leaflets, opening and closing of the 
leaflets and presence of calcification can be visualized (Figure 3) [46]. Unenhanced MDCT is preferred 
over contrast-enhanced images for the quantification of valvular calcification [46, 50]. 
 
Figure 3: Oblique view of the left ventricle and ascending aorta (a) the aortic valve is completely closed. Three 
aortic leaflets are visible with normal closure (b).Aortic valvular area (AVA) is determined at maximum opening 
(c). 
Chen et al [51] used ECG-gated CT angiography for the functional assessment of the valves. They 
visualized both healthy valves and also the valve conditions such as aortic stenosis, mitral stenosis, 
pulmonary stenosis, and tricuspid stenosis. They concluded that the valve thickness, opening, closing 
and the calcification can be observed very well by the CT angiography. Thus, CT angiography can 
provide useful information for the surgery planning.[51]  
By construction of intravascular views of CT datasets, three-dimensional volume rendering can also be 








Figure 4: Two frames of four-dimensional movies showing an intra-vascular view of the cardiac valves. 
Surgical aortic valve replacement is the traditional way of treating severe aortic stenosis. However, this 
type of open-heart surgery is too risky for some patients. Minimally invasive Transcatheter Aortic Valve 
Implantation (TAVI) has become an option for these patients. CT plays a major role in TAVI planning 
by providing information about the aortic annulus dimensions to determine the correct prosthesis size 
[52]. Choosing the appropriate size of prosthesis for the intervention is one of the most crucial part of 
the surgical planning of TAVI as annulus - prosthesis mismatch may lead to serious injury or death [53].  
 Conclusion 
In conclusion, cardiovascular diseases are the leading cause of death. CAD and the structural heart 
diseases are the two major cardiovascular disease groups. 3D reconstructions of CT images proved 
themselves useful in supplying crucial spatial information to medical professionals. Biomarkers such as 
CT based calcium scoring and treatment techniques such as TAVI makes CT the main imaging modality 
that can provide solutions both in diagnosis and surgical planning of cardiovascular diseases. 
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Scope of the Thesis 
This thesis aimed to explore the role of Computed Tomography in the field of cardiovascular research 
mainly on coronary artery disease and valvular diseases. The thesis is composed of two parts namely 1) 
Coronary Morphology and Plaque, 2) Aortic Valve Measurement 
Part 1 Coronary Morphology and Plaque 
Chapter 2 investigated the association between the coronary artery geometry with presence and extent 
of coronary artery disease using non-invasive coronary computed tomography angiography. Curvature 
and tortuosity were measured based on the centerlines of the coronary arteries as the metrics of the 
coronary artery geometry. Association of these metrics with significant coronary artery stenosis (as 
>70% luminal narrowing) and presence of plaque assessed in order to investigate this relationship. 
Chapter 3 investigated two question. First question is whether the geometry of coronary artery 
geometry changes between end-systolic and end-diastolic phases. Second question is whether the 
dynamic change of coronary artery geometry is related with the coronary artery disease. In this study in 
addition to curvature and tortuosity, inflection points were counted as one of the metrics of coronary 
artery geometry.  
Chapter 4 introduced a technique to correct the influence of lumen contrast enhancement on non-
calcified atherosclerotic plaque Hounsfield-Unit values in CT images in order to obtain the correct HU 







previously determined exponential decline pattern of HU on the lumen wall caused by the contrast 
agent. 
Part 2 Aortic Valve Measurement 
Chapter 5 is a systematic review aimed to review the literature on application of 3D printing to valvular 
diseases. In this regard, constraints and the possibilities of 3D printing in this field are discussed based 
on the published literature. Data preparation, time requirements, printer possibilities, and material 
properties are discussed as the main technical issues. Furthermore, the clinical applications of the 3D 
printed models of heart valves are investigated in this systematic review. 
Chapter 6 is describing the design and validation of a pulsatile pump and a mock circulatory system. 
The aim of this study is to create a phantom set up that mimics the circulatory system with variable 
frequency and stroke volume. This phantom setup is planned to be used in validation tests and other 
development purposes such as image processing and medical device testing.  
Chapter 7 presents a semi-automatic segmentation technique to quantify the aortic valve area. The aim 
of this study is to develop a fast and reliable quantification technique. The developed algorithm is 
validated with the gold standard echocardiography. Furthermore intra- and inter- reader variabilities, and 
measurement durations of manual and presented semi-automatic segmentation techniques were 
compared. 
Chapter 8 is the second systematic review presented in this thesis. This systematic review has its 
question on its title “Does the Aortic Annulus undergo dynamic conformational changes during the 
cardiac cycle?”. The answer of this question has utmost importance in the surgical planning of the 
transcatheter aortic valve implantation as the prosthesis selection of these procedures are based on the 
aortic annulus measurements and mis-sizing can lead to aortic regurgitation or rupture of the aortic root 































Chapter 2 Non-invasive assessment of 
coronary artery geometry using coronary 
CTA 
Publication: Non-invasive assessment of coronary artery geometry using coronary CTA 
Tuncay V, Vliegenthart R, den Dekker MAM, de Jonge GJ, van Zandwijk JK,van der Harst P, Oudkerk 
M, van Ooijen PMA.  
Journal of Cardiovascular Computed Tomography 2018;12(3):257-260 
Conference paper: Tortuosity and Curvature of the Coronary Arteries in Relation with Coronary Artery 
Disease  
V. Tuncay, P. M. Van Ooijen, M. Oudkerk, M. A. den Dekker, R. Vliegenthart, E. R. van den Heuvel. 









Atherosclerotic plaques evolve over time and can cause narrowing of coronary arteries with 
subsequently reduced downstream blood flow. Development and progression of plaque is complex and 
not yet fully understood. One of the mechanical factors affecting the plaque process is shear wall stress 
[1-3]. In-vivo studies have shown that predominant low shear stress is predominantly present in the 
inner curvature of the vessel. Atherosclerotic plaque distribution is reported to be associated with the 
vessel curvature, as well as with vessel bifurcations [1, 4]. The methods used to obtain these data were 
invasive techniques that can only be applied in symptomatic patients with clinical indication for invasive 
coronary angiography, resulting in biased samples. However, gaining insight in the relationship between 
three-dimensional vessel geometry and plaque development could be of great importance to allow early 
detection of individuals at increased future risk of developing CAD. We investigated the relationship 
between coronary curvature and tortuosity with presence and extent of CAD using non-invasive 
coronary computed tomography angiography (cCTA). 
Methods 
Patients and Cardiac CT protocol 
Current study is a sub-study of the GROUND-2 study, which evaluated the presence of silent CAD in 
cardiac asymptomatic patients with known extra-cardiac arterial disease [5]. The medical ethical 
committee waived the need for additional approval for this retrospective analysis. From GROUND-2 
participants with cCTA data (n=75), only those with reconstructions at end-diastolic phase were 
included (n=73, 97.3%), to enable comparison of curvature and tortuosity based on the same phase in 
the cardiac cycle. 
CT scans were performed on a dual-source CT scanner (SOMATOM Definition, Siemens, Erlangen, 
Germany). cCTA was performed in spiral mode, using retrospective electrocardiographic gating, the 
common approach for cCTA acquisition at time of inclusion.  
During the GROUND-2 study, attending radiologists with (cCTA experience from 5 to >10 years) 
evaluated the cCTA data for presence and severity of CAD [5]. Presence of plaque and stenosis were 
assessed per segment, according to the 15-segment modified American Heart Association classification 
[6]. >70% luminal narrowing was interpreted as significant stenosis. Detailed information on the 






inclusion, the CT scan / evaluation protocol and the population characteristics can be found in the 
previous publication [5]. 
Assessment of Coronary Artery Geometry 
Geometry assessment was performed using dedicated software (Aquarius iNtuition Ver.4.4.11, 
Terarecon, San Mateo, USA). Following automatic ribcage removal, related cardiac workflow steps 
were selected for detailed inspection of the main coronary arteries (right coronary artery (RCA) 
(segment 1-3), left main (LM) (5), left anterior descending artery (LAD) (6-9), and left circumflex artery 
(LCX) (11,13)). The coronary arteries could be selected on the transverse slices or on the volume-
rendered reconstruction, resulting in a curved multi-planar reformat reconstruction (cMPR) of the 
selected vessel with automatic centerline extraction. Curvature and tortuosity measurements were 
performed based on the centerline of the coronary artery selected in the three-dimensional view (Figure 
1). Selected arteries were stretched in the cMPR for determination of the start and end points of the 
segments (Figure 2). Each segment was marked manually (Figure 2) followed by curvature and 
tortuosity measurements of the marked region based on the three-dimensional course of the centerline. If 
needed, centerlines were manually corrected. Measurements were performed for each segment (Figure 
2a), and for the entire vessel (Figure 2b). Segments with an average diameter of less than 1.5 mm were 
excluded, to ensure reproducibility. Initially segments 1-3, 5-9, 11, and 13 were assessed (730 








Figure 1: Volume rendered computed tomography image of a segmented right coronary artery. 







Figure 2: Example of the right coronary artery in curved multiplanar reformat reconstructions. Segments are 
separated by the red markers. Curvature and tortuosity are measured for (a) segment 1, and (b) whole vessel. 
Local curvature was calculated between a selected point, a point 5 mm before and a point 5 mm beyond 
on the centerline, at every 5 mm using Menger’s curvature[7]. The scale of the interval was decided 
after testing intervals from 1 mm to 20 mm with 1 mm increment, as it is known that smaller scales lead 
to fluctuation, whereas larger scales become less sensitive to sharp local bends.. Average of the local 







Tortuosity was defined as the total length of the centerline divided by the straight distance between 
begin and endpoint of the indicated range on the centerline[8, 9]. Intra-reader agreement for geometry 
measures was assessed for all scans by having one experienced reader perform all measurements twice 
at a three-week interval. To assess inter-reader agreement, a second reader independently evaluated 20 
randomly selected scans. 
Statistical Analysis 
Intra-class correlation coefficients (ICC) were calculated to assess the reproducibility [10]. Systematic 
intra- and inter-reader differences were assessed by Bland-Altman analysis.  
To investigate the association between a significant stenosis and curvature or tortuosity, a linear mixed 
model was applied for curvature and tortuosity separately. The analyses were performed at the segment 
level and at the artery level (RCA, LM, LAD, and LCX). Association and interaction analyses were 
corrected for age, sex and hypertension. All statistical tests were two-sided. Statistical analyses were 
performed using SAS version 9.3 (SAS Institute Inc., Cary, NC, USA) and IBM SPSS Statistics version 
20.0.0.1 (SPSS Inc., Chicago, IL, USA).  
Results 
Study Characteristics 
Seventy-three participants (76.3% males, mean age 64.8 ± 8.1 years) with a cCTA dataset reconstructed 
at end-diastolic phase could be included in this sub-study. Characteristics of the participants are shown 
in Table 1. The prevalence of cardiovascular risk factors was high. For the total population of the 
GROUND-2 study the prevalence of significant CAD was 56.8%. Median curvature and tortuosity were 
respectively 0.094 [0.071; 0.120] and 1.080 [1.040; 1.120] on segment level, and 0.096 [0.078; 0.118] 












Table 1: Clinical characteristics of the study population.  
 All patients (N=73) 
Age (years) 64.8 ± 8.1 
Male gender (%) 76.7 
Body mass index (kg/m2) 26.2 ± 3.8 
Systolic blood pressure (mmHg) 140 ± 24 
Diastolic blood pressure (mmHg) 79 ± 9  
Hypertension (%) 82.2 
Cholesterol (mmol/L) 4.7 ± 1.2 
Triglyceride (mmol/L) 2.02 ± 1.8 
HDL cholesterol (mmol/L) 1.2 ± 0.4 
LDL cholesterol (mmol/L) 2.9 ± 0.9 
Dyslipidemia (%) 93.2 
Glucose (mmol/L) 5.8 ±1.1  
Diabetes mellitus (%) 9.6 
Smoking (%) 32.9 
Significant stenosis prevalence (%) 46.6 
Plaque prevalence (%) 82.2 
Continuous variables are expressed as mean ± standard deviation or median (25th, 75th percentile), 








Reproducibility and Reader Agreement 
The overall ICC showed excellent intra-reader agreement (ICC>0.80) for tortuosity and curvature 
measurements. Inter-reader agreement was found to be good for curvature (ICC=0.73) and excellent for 
tortuosity (ICC=0.92). 
Bland-Altman analysis showed a mean intra-reader difference for curvature and tortuosity of -0.0013 
(95% CI:-0.0398, 0.0425) mm-1 and 0.0011 (95 % CI:-0.1755,0.1734), respectively. Mean inter-reader 
difference for curvature and tortuosity were 0.0036 (95% CI: -0.0513, 0.0585) mm-1 and 0.0236 (95% 
CI:-0.1606, 0.2078), respectively. Association between Vessel Geometry and Stenosis. 
Association between Vessel Geometry and Stenosis 
A significant association was observed between curvature and significant stenosis both at segment level 
(p<0.001) and artery level (p=0.002) (Table 2). Patients with a significant stenosis had 16.7% and 13.8% 
higher curvature at segment and artery level, respectively, than patients without stenosis.  
Table 2: Association of curvature and tortuosity with significant stenosis, corrected for age, sex, and 
hypertension. 
Measure 





















There was an association between tortuosity and significant stenosis at segment level (p=0.002). There 
was interaction for tortuosity at segment level (p=0.041), indicating that the relationship between 
tortuosity and significant stenosis is not the same across segments. 






Association between Vessel Geometry and Presence of Plaque 
A significant association was observed between curvature and plaque presence at both segment 
(p<0.001) and artery level (p<0.001) (Table 3). For instance, segments with a plaque had 17.6% higher 
curvature than segments without coronary plaque. There was also an association between tortuosity and 
plaque presence at segment level (p<0.001). On average, segments with plaque were 30.8% more 
tortuous. The interaction of tortuosity and plaque presence indicated the association was not the same 
across segments (p=0.013). 
Table 3: Association presence of plaque with curvature and tortuosity corrected for age, sex, and 
hypertension 
Measure 






















Measures of coronary artery curvature and tortuosity can be derived reproducibly based on semi-
automatic analysis of cCTA. Curvature of the coronary arteries was more related to the presence of 
significant stenosis and plaque than tortuosity. Our findings provide a preliminary indication that higher 
curvature of the vessels may indicate sites that are prone to plaque development, which should be 
studied in follow-up studies. In conclusion, coronary artery geometry measures are potential imaging 
biomarkers for future risk assessment of CAD, based on common cCTA examinations. 
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Coronary artery disease (CAD) is the most common type of heart disease and the leading cause of death 
worldwide [1]. Hemodynamics and geometry of the coronary artery have been suggested to play a role 
in the development of atherosclerotic plaque, but these relationships are complex and still matter of 
debate [2]. Previous hemodynamic studies using flow simulations in static vessel models suggest an 
association between low wall shear stress and coronary plaque development. Thus, there may be 
preferred sites for plaque development depending on mechanical factors [2–6]. In studies on coronary 
hemodynamics in simulations incorporating cardiac motion, the importance of considering 
physiologically realistic flow and vessel motion was stressed [7–11]. This implies the need for in vivo, 
patient studies.  
So far, the only evidence regarding dynamic changes of the coronary geometry originates from invasive 
coronary angiography (ICA). ICA is still considered the reference standard for the diagnosis of CAD, 
but is limited by its invasiveness and its lack of information about plaque characteristics [12]. There are 
scarce data from ICA studies about coronary geometry and the relation with CAD related events. Zhu et 
al. classified human coronary geometry in a single, diastolic phase [13]. O’Loughlin et al. found that the 
ratio of segment length between systolic and diastolic phase can predict the location of future culprit 
lesions causing myocardial infarction [14]. Coronary computed tomography angiography (cCTA) is a 
non-invasive imaging technique that is nowadays an accepted alternative in coronary artery evaluation 
[15]. cCTA is safer and cheaper than ICA, and associated with less discomfort to the patient. Three-
dimensional change in coronary artery geometry during the cardiac cycle and its relationship to CAD 
can be investigated using cCTA with electrocardiographically synchronized data acquisition during 
systolic and diastolic phase. A previous study correlated the ratio of coronary artery length between end-
systolic (ES) and end-diastolic (ED) phases with the location of atherosclerotic lesions, based on dual-
source CT [16]. Only information about the length of coronary segments was obtained, rather than 
specific geometric information. Recent dedicated software packages now enable the extraction of 
quantifiable three-dimensional parameters of vessel geometry, derived from multiple phases of the 
cardiac cycle in cCTA. In a recent cross-sectional study, cCTA-derived, a relationship between 
measures of curvature and tortuosity in a single cardiac phase, and the presence and extent of CAD was 






found [17]. Whether dynamic change of coronary curvature and tortuosity through the cardiac cycle 
affects the relationship with CAD, is unknown.  
The current study focuses on the assessment of coronary artery geometry through the cardiac cycle 
based on cCTA, and the association of dynamic change in coronary artery geometry with CAD. Our 
hypotheses are 1) coronary artery geometry changes dynamically during the cardiac cycle; 2) the degree 
of stenosis and plaque types are related to dynamic changes in geometrical parameters. The novelty of 
this research resides in its uniqueness to quantify characteristics of movement of the coronary arteries 
during the cardiac cycle in a non-invasive and three-dimensional way, and in the derivation of new 
quantitative imaging biomarkers based on cCTA scans. 
Methods and Materials 
Patients 
Data from patients involved in different scientific studies from April 2006 until April 2007 were 
included in this retrospective analysis [18–20]. Patients had either a high probability of CAD,(18) were 
planned for elective conventional invasive coronary angiography (ICA),[19] or were assessed at the 
emergency department because of acute chest pain [20]. Patients were excluded if they had previous 
heart surgery or percutaneous coronary intervention (PCI), or if they had a coronary anomaly on cCTA. 
cCTA was performed at a single tertiary center. Approval from the Medical Ethical committee was 
originally obtained for each scientific study, and informed consent was obtained from all patients at the 
time of inclusion. For the current analysis, the Medical Ethical committee waived informed consent 
requirement because of the retrospective nature of this study without additional burden to the patients 
involved. 
Coronary CT Angiography Scan Protocol 
cCTA was performed on a first-generation dual-source CT system (SOMATOM Definition, Siemens, 
Erlangen, Germany) using a standardized protocol. The standard scanning protocol involved spiral 
scanning at 120 kV with retrospective ECG gating. Patients were administered intravenous beta-
blockers (metoprolol, 5-20 mg) if the heart rate was above 65 beats per minute, unless in case of 
contraindications to beta-blockers. All patients were given sublingual nitroglycerin (0.4 mg) prior to the 
scan protocol. Table pitch was dependent on the heart rate, with a cranio-caudal scan direction starting 







scan acquisitions were made with a non-ionic contrast agent (Iomeprol 400 mg I/ml, Iomeron® 400, 
Bracco, Italy) with contrast volume and infusion rate individually determined for each patient. Piers et 
al. [19] described the scan protocol in more detail. The mean dose length product (DLP) was 1323 ± 288 
mGy.cm (22.5 ± 4.9 mSv). To be included for the current analysis, reconstructions needed to have been 
made at every 10% of the RR-interval, with a reconstructed slice thickness of 2.0 mm based on 64 x 0.6 
mm slice collimation (originally reconstructed for functional analysis). 
Coronary Artery Assessment 
Radiologists with experience in cardiac CT ranging from 5 to over 10 years evaluated the cCTA data for 
presence and severity of CAD as part of the research projects. Coronary evaluations were performed 
using dedicated advanced visualization software (Syngo, Siemens, Erlangen, Germany). Presence of 
plaque, plaque type (calcified, non-calcified, and partly calcified) and degree of stenosis were assessed 
per segment, according to the 15-segment modified American Heart Association (AHA) classification 
[21]. 
Coronary Artery Geometry Assessment 
Reconstructed cCTA data were loaded onto a dedicated workstation (Aquarius iNtuition, Ver.4.4.11, 
TeraRecon, San Mateo, USA). A built-in threshold-based left ventricular ejection fraction (LVEF) 
analysis function automatically determined the ES and ED phase of the cardiac cycle based on 
respectively the minimum and maximum filling of the left ventricle. For the current study, in case the 
reconstruction quality of the coronary arteries in the automatically determined ES or ED phase was too 
low, another phase with diagnostic depiction of the coronary arteries was selected up to two phases 
shifted from the minimum or maximum filling. If optimal quality could not be obtained based on these 
restrictions, the coronary artery was excluded from further analysis. 
The resulting ES and ED phases were used for detailed inspection of the coronary arteries and its 
individual segments, according to the 15-segment modified AHA-classification [21]. For the right 
coronary artery (RCA) we assessed the proximal, mid, and distal segment. For the left coronary artery 
we assessed the left main artery, proximal, mid, and distal segment of the left anterior descending 
(LAD) artery, and the proximal and distal segment of the left circumflex (LCx) artery. On artery level, 
the RCA, LAD, and LCx were assessed separately. In cases where no side branches where present to 
identify the end of the segment, we maintained equal pre-set lengths in both ES and ED phase to make 






sure comparable parts of the vessel were considered. Segments were terminated or excluded when they 
were smaller than 1.5 mm in average diameter, had a bad reconstruction quality due to the presence of 
artefacts or incorrect centerline extraction, or were not visible at all. Arteries were excluded if one or 
more segments could not be assessed. 
The coronary arteries were selected on the three-dimensional volume-rendered reconstruction (see 
Figure 1) or transverse slices in the relevant phase in order to initiate automatic centerline extraction of 
an artery. The curved planar reformation (CPR) view was reconstructed based on this centerline, after 
which it was manually adapted to ensure the most appropriate implementation of this centerline. 
Markers were applied at the beginning and endpoint of a segment. Measurements were performed for 
each segment and each entire artery.  
 
Figure 1: Example of a volume rendered 3D image with centerline extractions of the RCA (selected) and LAD at 
70% of the RR-interval (ED phase). 
Local curvature was calculated using Menger’s formula, at every 5 mm. The average of the local 
curvature for the selected path is given in mm-1 as the final result for curvature. The ratio of the total 
path length to the straight distance between begin and endpoint of the indicated range was calculated to 







intersections (inflection points) that the straight connection between beginning and endpoint has with the 
centerline when rotating the CPR view. 
Statistics 
Normality of the data was assessed using Shapiro-Wilk analysis. Based on the available sample size of 
arteries and segments, data were considered to have a normal distribution when the test statistic was 
greater than 0.9. Curvature, tortuosity and number of inflection points were assessed in the ES and ED 
phase. For curvature and tortuosity, differences were calculated as the value in ES phase minus the value 
in ED phase. For number of inflection points, absolute differences were assessed. The differences 
between ES and ED phase curvature and tortuosity measurements were tested with linear mixed model. 
The results were corrected for segment and artery information. On the other hand, the differences 
between number inflection points were tested with the non-parametric Wilcoxon signed-rank test.  
Linear mixed models were applied to investigate associations between change in geometrical parameters 
and the severity of CAD. Severity of CAD was categorized into a number of dichotomous variables: no 
plaques and plaques with no lumen narrowing (LN negative group) versus plaques with lumen 
narrowing (LN positive, this group includes all degrees of narrowing), plaques with <50% stenosis 
versus plaques with >50% stenosis, and plaques with <70% stenosis versus plaques with >70% stenosis. 
Associations of change in geometrical parameters with plaque types (calcified, non-calcified, and partly 
calcified) were investigated using linear mixed models. Estimated marginal means were used between 
groups in the linear mixed model depicting lumen narrowing, stenosis or plaque type.  
All statistical analyses were performed in IBM SPSS Statistics version 22.0.0.1 (SPSS Inc, Chicago, 
USA). Significance for difference was expressed with p-values, where a two-tailed p-value of <0.05 was 
considered significant. 
Results 
Seventy-one patients in whom at least one artery could be assessed were included in this study. Mean 
age was 62.2 ± 9.9 years, and 87.3% were men. In total 213 arteries and 639 segments were assessed, of 
which 137 arteries (64.3%) and 456 segments (71.4%) could be included. Arteries and segments that 
could not be assessed either did not have sufficient quality in both phases, or were too small. The group 
of arteries consisted of 53 RCA (38.7%), 45 LAD (32.8%), and 39 LCx arteries (28.5%). 114 arteries 






(83.2%) and 270 segments (59.2%) contained plaque. 0%, <50%, 50-70% , and >70% stenosis were 
observed in 5 (3.6%), 42(30.7%), 18(13.1%), and 49 (35.8%) of the arteries respectively. On segment 
level 0%, <50%, 50-70%, and >70% stenosis were observed in 51 (11.2%), 101(22.1%), 43(9.4%), and 
75(16.4%) of the segments respectively.  
In systole, the segments were most frequently best assessable at 40% of the R-R interval (n=227, 49.8%, 
range 5-60%). In 11.6% of the segments, deviation was needed from the original, software-indicated ES 
phase due to low reconstruction quality or motion artefacts. In diastole, the segments were most 
frequently best assessable at 90% of the R-R interval (n=172, 37.7%, range 70-110%). In 66.9% of the 
cases we deviated from the original ED phase. Although the assessed cases at 110% (i.e. 10%) of the 
RR-interval (n=41, 9.0%) are strictly part of the subsequent cardiac cycle, they were found to have a 
sufficient filling of the left ventricle to be assessed as diastolic phase.  
Table 1 shows overall values for curvature, and tortuosity in ES and ED phase on (individual) artery and 









Figure 2: Geometrical measurements of the LAD at 30% in ES phase (A) and at 70% in ED phase (B). According 
to these measurements, the LAD has 26% higher curvature, and 3% higher tortuosity in ES phase. The white 
arrows indicate one inflection point in both phases. 
Curvature 
Curvature in ES and ED phase, and differences in curvature were normally distributed. Compared to the 
ED phase, the mean curvature was 11.1% higher in the ES phase on artery level (p=0.002), and 8.9% 
higher on segment level (p<0.001) (Table 1). 
Tortuosity 
Tortuosity differences were normally distributed. The mean tortuosity was 2.3% higher in end-systole 
than in end-diastole on artery level (p=0.09), and 1.8% higher on segment level (p=0.005) (Table 1). 







The difference in number of inflection points was not normally distributed on artery and on segment 
level (Shapiro-Wilk statistic value 0.755 and 0.564, respectively (both p<0.001)). The mean number of 
inflection points was significantly higher at ES phase than at ED phase for both artery (Z=3.793, 
p<0.001) and segment level (Z=5.415, p<0.001) (Table 1). 
Table 1: Outcomes of the measured parameters in end-systolic (ES) and end-diastolic (ED) phase on 
artery and segment level, depicted as mean (mean standard error). Significant differences are indicated 
with an asterisk. 
 Arteries (n=137) Segment (n=456) 












ED 1.33(0.026 1.10(0.005) 
Inflection points ES 2.20(0.095) 
<0.001* 
0.63(0.038) <0.001* 
ED 1.96(0.091) 0.51(0.034) 
 
Associations between Geometrical Parameters and Stenosis  
There was no significant association between the change in geometric parameters through the cardiac 












Table 2: Linear mixed model associations between geometrical parameters and stenosis on artery level. 
Dependent variables (differences between ES and ED values) are depicted in the rows, factors in columns. LN- 
means group with no lumen narrowing, LN+ the group segments with lumen narrowing. EMM are estimated 

























































(0.08) .031 (0.08) 0.185 0.24 (0.07) 0.23 (0.10) 0.913 
 







Table 3: Linear mixed model associations between geometrical parameters and stenosis on segment level. 
Dependent variables (differences between ES and ED values) are depicted in the rows, factors in columns. LN- 
means group with no lumen narrowing, LN+ the group segments with lumen narrowing. EMM are estimated 
marginal means, with in parenthesis the standard errors. 
Change in 
Geometrical 


















(0.03) 0.339 0.13 (.003) 0.10 (0.04) 0.624 
 
Associations between Geometrical Parameters and Plaque Types 
Association results for plaque type are given in Table 4. None of the dynamic geometrical parameters 
were significantly associated with type of plaque. 
Table 4: Linear mixed model associations between geometrical parameters and plaque type at segment level. 
EMM are estimated marginal means, with in parenthesis the standard errors.  
Change in Geometrical  
Parameters (∆) Calcified Non-calcified Partly calcified P-value 
Curvature (mm-1) 
EMM 0.007 (0.002) 0.005 (0.003) 0.010 (0.002) 0.427 
Tortuosity 
EMM 0.018 (0.004) 0.015 (0.006) 0.020 (0.004) 0.796 
Inflation points 









This study shows that the geometric parameters of coronary arteries change significantly between the ES 
and ED phase except for the tortuosity at the artery level. However, we found no significant relationship 
between geometric changes through the cardiac cycle and extent of CAD. To our knowledge, this is the 
first patient study quantifying coronary geometry during the cardiac cycle based on straightforward post-
processing of four-dimensional non-invasive imaging data. 
Previous studies focusing on the relation between vessel geometry, corresponding hemodynamics, [7–
9,11] and plaque development [6,22–24] were often based on computational fluid dynamics, and were 
thus accompanied by modeling assumptions requiring a considerable amount of time and computational 
capacity [6,25]. These studies found that hemodynamic and geometric parameters can be linked to 
(early) plaque development, but conclusions were drawn based on modeling or static approaches of the 
coronary arteries. Moreover, there have been studies quantifying and cataloguing the geometric 
parameters of coronary arteries with invasive imaging techniques. Zhu et al. used ICA to measure 
geometry of the proximal, mid, and distal segments separately of the RCA and LAD in one phase, and 
found, for instance, a two-fold difference in maximum curvature in LAD segments between individuals. 
They state that a particular geometric feature must exhibit large variability between vascular regions or 
individuals, if it should be considered as an atherosclerotic risk factor. They also suggested to add a 
dynamic dimension in addition to their work, which can create even more variability [13]. In the study 
of Johnson et al, biplane cine angiography was used for the quantifications, which is an invasive method 
in contrast to CT, and so only applicable in selected patients at high suspicion of CAD. Furthermore, this 
involves two projection directions, requiring additional reconstruction algorithms to obtain three-
dimensional information [26]. In a recent study, Tuncay et al. assessed the relationship between 
curvature and tortuosity of coronary arteries and the presence of significant stenosis and plaque [17]. 
They reported that static coronary artery geometry is related with the presence of plaque and significant 
stenosis. However, in this study all the analyses were done in diastolic phase. The effect of dynamic 
change of coronary artery geometry was not investigated. The only patient study slightly resembling 
ours was conducted by O’Loughlin et al., [16] but they only investigated the length of segments, and 
only included a few segments of the coronary tree. Strength of our study resides in the fact that coronary 
arteries were geometrically quantified based on four-dimensional cCTA data involving multiple phases 






of the cardiac cycle. Our method involves more detailed and three-dimensional geometric information in 
terms of curvature, tortuosity, and inflection of both segments and arteries, through the cardiac cycle.  
This study has some limitations. Firstly, we performed measurements based on a semi-automatically 
extracted centerline in the CT datasets. The centerline creation did not always yield an accurate result. 
Especially extraction of severely diseased coronary arteries was frequently incorrect, thus requiring 
manual adaptation of the centerline to achieve a better match with the vessel trajectory. This could have 
affected our geometric measurements. Secondly, corresponding segments from the same patient were 
equivalently adapted in both phases to minimize intra- and inter-observer variability, but this is still a 
possible shortcoming of the study since variability was introduced. Furthermore in case image quality at 
the automatically determined ES or ED phase was too low, another phase was selected up to two phases 
from the minimum or maximum filling. This might also compromise the assessment of dynamic 
geometry change of coronary arteries between ES and ED phase. Furthermore, this is a retrospective 
non-randomized study. Same quantification technique can be employed in a randomized prospective 
study with a larger patient group in order to further investigate the relationship between dynamic 
behavior of coronary arteries and CAD. Finally, this study was performed using older dual-source CT 
technology, which at the time involved retrospective ECG gating for cCTA, resulting in high, nowadays 
outdated, radiation dose. We do not suggest to perform four-dimensional CT imaging of the coronary 
arteries for clinical routine, but merely used the existing data from previous studies to extract additional 
information which allowed to test our hypothesis on geometrical changes through the cardiac cycle, and 
its relation to CAD. However, with newer CT technology, it is possible to modulate tube current during 
the cardiac cycle, which allows evaluation of multiple phases from systolic to diastolic phase (f.e. 30-
70%) at acceptable radiation dose. 
Conclusion 
In conclusion, this study investigated the dynamic behavior of coronary artery geometry during the 
cardiac cycle and its relationship to CAD using four-dimensional, non-invasive imaging method. 
Curvature, tortuosity and inflection points measures were significantly higher in ES phase compared to 
ED phase for coronary arteries as well as individual coronary segments. While absolute measures of 
curvature and tortuosity were related to presence and extent of CAD, dynamic change of vessel 







invasive quantification of coronary geometry through the cardiac cycle that helps to study potential 
biomechanical mechanisms underlying CAD development. 
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Chapter 4 Towards Quantification of Non-
Calcified coronary Atherosclerotic Plaque 
on CT: Correction of Lumen Contrast-
Enhancement Influence. 
Publication: Correction of lumen contrast-enhancement influence on non-calcified coronary 
atherosclerotic plaque quantification on CT 
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In coronary artery disease (CAD), atherosclerotic plaque develops in the wall of the coronary artery, 
potentially leading to significant narrowing of the lumen and/or occlusion of the artery, hindering the 
blood supply of the heart muscle. An acute coronary syndrome (ACS) as a result of CAD is currently the 
leading cause of death in the western world [1]. Early detection of CAD is essential in order to start 
treatment timely and prevent or delay the progress of disease.  
 Previous publications demonstrated that coronary stenosis [2, 3] and calcified plaque burden [4-6], two 
main parameters for estimating CAD event risk, can be quantified reliably by multi detector-row 
computed tomography (MDCT). 
Quantification of non-calcified plaques is of increasing interest in diagnosis and clinical workup as 
plaques with large lipid-rich components are considered to be more rupture prone and subsequently are 
more likely to cause an ACS [7]. One of the most common and most validated methods to identify and 
quantify lipid-rich plaque is intravascular ultrasound [8, 9]. However, identification of lipid-rich plaque 
using MDCT is highly preferable because of its non-invasive nature. MDCT can reportedly characterize 
non-calcified plaques by virtue of their specific CT density in Hounsfield Units (HU) [10-13]. However, 
to use a generalized HU-criterion is not yet possible as the reported HU-values vary considerably. Many 
factors have been reported to influence non-calcified coronary plaque HU values, one of the most 
prominent being the lumen contrast-enhancement [14-18]. In a preliminary software phantom simulation 
study, the lumen contrast-enhancement was shown to influence the surrounding coronary wall with a 
specific pattern [19]. This vessel phantom study aimed to construct and validate an algorithm to correct 
for the lumen contrast-enhancement influence in order to obtain the correct HU values for the 
characterization and quantification of non-calcified plaques. 
Material and Methods 
Several specifically designed coronary vessel phantoms (QRM GmbH, Moehrendorf, Germany) were 
used in this study. Using these phantoms, the previously found lumen contrast-enhancement influence 
pattern was reproduced. Based on the reproduced patterns, a generalized correction algorithm was 
constructed and validated. 







Three coronary vessel phantoms with 1, 2, and 4 mm diameter circular hollow lumina were used in the 
experiment. The vessel wall was designed to be 35 HU in CT density and 3 mm in thickness, and part of 
each vessel phantom was infested with an artificial plaque of -10 HU in CT density, 2 mm in thickness, 
and 5 mm in length (Figure 1A, these 2 different segments of the wall will be referred to as normal and 
plaque-infested wall, respectively, for the remainder of the article). 
 
Figure 1: The phantom diagram (A) and experimental setup (B). 
The phantoms were scanned simultaneously while submerged in sun flower oil with a dual-source 
computed tomography scanner (Siemens Definition, Siemens Medical Solution, Forchheim, Germany) 
at 120kV, 300mAs/rot, and 64x0.6mm (Figure 1B). Scanning was performed five times with the lumen 
alternately filled with water and 4 contrast solutions of approximately 100, 200, 300, and 400 HU. 
Images were reconstructed at 0.6 mm slice thickness with 0.4 mm increment. 
In total, 30 datasets were obtained with the following properties: 3 lumen sizes (1, 2, and 4 mm 
diameter) x 2 wall types (normal and plaque-infested wall) x 5 lumen contents (water or 1 of the 4 
different contrast solutions). 
Analysis 
The images were analyzed using a custom-made software tool written in Matlab® (Mathworks Inc, 







Analysis Sets Construction 
Two types of analysis sets are constructed from each datasets, a training set and a validation set. A 
training set was constructed by averaging the 10 selected slices for every dataset, in order to minimize 
noise. This training set was then used to study the correlation between HU values of wall and lumen; 
and to extract the lumen contrast-enhancement influence pattern. 
A validation set was constructed by arbitrarily selecting one slice of each dataset. The validation set was 
used to apply and test the formulated lumen contrast-enhancement influence correction algorithm (see 
section Validation). 
Wall and Lumen ROI Segmentation 
Lumen and wall (normal and plaque-infested) HU-values were measured inside ROIs that matched the 
designed morphology. The lumen was semi-automatically detected using an algorithm used in a 
previous publication [20]. A circle of the designed lumen size is fitted to the detected lumen boundary to 
yield the lumen ROI. The wall ROI was defined as the area between the lumen circular ROI and a larger 
circle with the same axis and a diameter conforming to the designed plaque thickness. The wall ROI left 
out the outer part of the wall which is blurred by the partial volume averaging with the surrounding. 
Lumen Contrast –Enhancement Influence Pattern Extraction 
Pixel by pixel comparisons were performed between contrast-enhanced images (of lumen CT density: 
100, 200, 300, and 400 HU) and non-contrast-enhanced images (of lumen CT density: 0 HU) to extract 
the lumen contrast-enhancement. It is done by first aligning both images based on their outer vessel 
contour (obtained by 0 HU threshold [21]) and then subtracting the latter from the former (Figure 2). 
The comparisons resulted in difference images containing only the contribution of the contrast to the 
image (Figure 2C). The wall ROI from the previous step was used to delineate the wall area of the 
difference image (Figure 2D) and extract the contribution of the contrast to the wall area (Figure 2E). 
The value of every pixel inside this ROI was plotted against its distance from the lumen border. An 
exponential line ( cAey x += −λ ) was fitted through the data points, with A, λ, x, and c indicating the 
amplitude, coefficient, distance from lumen border, and constant, respectively, using a custom made 
Matlab® program which minimizes the squared error between the data points and the approximation 
line. 







Figure 2: Pixel by pixel comparison between contrast-enhanced image (A) and non-contrast-enhanced image (B) 
by subtracting the latter from the former, resulting in a difference image (C). The wall ROI (striped red line) was 
overlaid onto the difference image (D), from which the lumen contrast-enhancement influence on the wall was 
extracted (E). 
Validation 
In a previous study using software phantoms, it was demonstrated that the lumen contrast-enhancement 
influences the surrounding wall HU values up to a 2-pixel radius from the lumen border [19]. Therefore, 
the obtained lumen contrast-enhancement influence lines were applied to the contrast-enhanced image to 
correct for the lumen contrast-enhancement influence on the surrounding wall up to a 2-pixel radius 
from the lumen border.  
Non-contrast enhanced images of each vessel and wall type were defined as the reference images. The 
wall HU-values outside the 2-pixel radius were compared between contrast-enhanced images and the 
reference to check the validity of selecting only inside the 2-pixel radius for applying the correction 
algorithm. Subsequently, the wall HU-values for the inside 2-pixel radius and for the whole plaque, were 





Lumen contrast-enhancement influence pattern 
An exponential line ( cAey x += −λ  ) approximated the lumen contrast-enhancement influence on the 
surrounding wall (Figure 3). The lumen contrast-enhancement influence patterns for the two types of 
wall were similar for each vessel type, except for the smallest vessel (Figure 4).  
Figure 3: Typical lumen contrast-enhancement influence on the surrounding wall, plotted against the distance to 
the lumen border (blue dots), which was approximated by an exponential line (red line). 
The obtained influence patterns (Figure 4) were applied to the training set to correct for the lumen 
contrast-enhancement influence. The difference between the mean HU-values of the wall to the 
reference, before and after correction, can be seen at Table 1 (training set). 







Figure 4: The lumen contrast-enhancement influence patterns for large (A), medium (B), and small (C) vessels. 
Generalized Lumen Contrast-Enhancement Influence Pattern 
To enhance the applicability of the lumen contrast-enhancement influence pattern, a generalized version 
of the correction algorithm was formulated. Combining all the parameters of the exponential lines from 
all vessels and all types of wall, the amplitudes (A) were found to be linearly correlated to the mean 
lumen HU-values (r2 = 0.96), following a linear equation: 4_*66.0 += HULumenA  (Figure 5A). 
Meanwhile, the coefficients (λ) were similar: 0.9+0.1, and the constants (c) were linearly correlated to 
the mean lumen HU values (r2 = 0.64), following a linear equation: 2_*03.0 −−= HULumenc  (Figure 
5B). 
 
Figure 5: The correlation between the amplitudes (A) and the lumen mean HU values and between the constants 
(B) and the lumen mean HU values 
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The generalized correction algorithms were applied to the validation set to correct for the lumen 
contrast-enhancement influence (Figure 6 and 7). The differences of the walls mean HU-values to 
the reference, before and after correction, can be seen at Table 1 (validation set). 
Figure 6: The effect of the formulated correction algorithm on the normal wall. This figure shows the uncorrected 
contrast-enhanced image (A), the corrected contrast-enhanced image (B), and the non-contrast-enhanced 
reference image (C). The lumen border is shown by the solid magenta circle, and the 2-pixel radius by the striped 
magenta circle. The HU profiles along the vertical (yellow lines) and horizontal (cyan lines) directions of the three 
images are plotted on top of each other in image D and E, respectively. 







Figure 7: The effect of the formulated correction algorithm on the plaque-infested wall. This figure shows the 
uncorrected contrast-enhanced image (A), the corrected contrast-enhanced image (B), and the non-contrast-
enhanced reference image (C). The lumen border is shown by the solid magenta circle, and the 2-pixel radius by 
the striped magenta circle. The HU profiles along the vertical (yellow lines) and horizontal (cyan lines) directions 
of the three images are plotted on top of each other in image D and E, respectively. The range of the plaque 















Table 1: The difference of walls mean HU-values to the reference 
Set 
Part of the wall 
Measured 
Difference to Reference 
No Correction Correction 
Training 
Outside 2-pixel 
radius 0-7 HU (2 HU) NC 
Inside 2-pixel radius 0-95 HU (44 HU) 0-6 HU (1 HU) 
Whole wall 1-30 HU (11 HU) 0-4 HU (1 HU) 
Validation 
Outside 2-pixel 
radius 0-8 (2 HU) NC 
Inside 2-pixel radius 4-98 HU (45 HU) 0-15 HU (4 HU) 
Whole wall 1-30 HU (10 HU) 0-8 HU (2 HU) 
Note:  
1. The values on Difference to Reference columns indicate the range with the median in the bracket 
2. NC: no correction performed 
Discussion 
Many factors have been reported to influence the HU values of plaques [14, 22, 23], with lumen 
contrast-enhancement being the most prominent one. The lumen contrast-enhancement influence to the 
surrounding tissue is mainly attributed to partial volume effect [24]. This effect is inevitable because of 
the limited spatial resolution of current human CT hardware, relative to the coronary size. A review 
study on published HU-criteria to distinguish non-calcified coronary plaques [25] has investigated the 
possible role of the study characteristics to the variability of the HU-criteria. As shown in this review, 
the connection between the reported lumen-contrast enhancements and the HU-criteria failed to be 
established. Several studies managed to further investigate the lumen contrast-enhancement and showed 
that the influence was dependent on the location of plaque relative to lumen [17, 18], with stronger 






influence on CT attenuation of non-calcified plaque close to the lumen. New development involving 
dual energy CT managed to virtually remove of contrast-enhancement [26] but is not yet applicable in 
contrast-enhancement removal at coronaries.  
A previous study, [19] using a software simulation has identified the exact pattern of lumen contrast-
enhancement. The same pattern, which resembles one-half of an exponential sigmoid curve, has been 
previously used as an image edge model [27]. By using CT experiment on vessel phantoms, this current 
study managed to reproduce and validate this lumen influence pattern ( cAey x += −λ ) in data obtained 
using clinical CT protocols on a clinical CT scanner. The amplitudes (A), which determine the 
magnitude of the exponential pattern, showed strong positive linear correlation to the lumen HU values 
which can be explained by the fact that CT is a linear system. The lambda (λ) coefficients express the 
range of the exponential pattern. The fact that they are relatively stable confirms that the influence range 
is mostly dependent on the spatial resolution of the CT system. The negative linear correlation between 
the constants (c) and the lumen HU-values may first seem counter intuitive as this will decrease the 
influence as the lumen HU values increase. This finding may be due to the Gibbs phenomenon, 
commonly associated with discontinuities in images [28]. However, the relatively weak correlation and 
small values indicate that this effect is not prominent. The close similarity of the influence patterns 
between all types of wall indicates the independency of wall types. The slight dissimilarity in the 
influence patterns between the two wall types of the small vessels (Figure 6C – influence from 100 and 
200 HU lumen value) was caused by the difficulty to correctly segment the boundary of the small 
(approximately 2 pixels diameter) and low attenuation lumina.  
The proposed correction algorithm managed to correct for the lumen contrast-enhancement influence on 
the most affected wall region, which is within a 2-pixel radius from the lumen border, reducing the 
median difference of 45 HU to a median difference of 4 HU, with reference to non contrast-enhanced 
vessel. When the whole wall region was measured, the median difference decreased from 10 HU to 2 
HU. 
A limitation of the study is that the HU values of the vessel wall (either the normal or the plaque-
infested wall) do not specifically refer to any of the published plaque-specific HU values. However, the 
pattern of the lumen contrast-enhancement influence is independent to the wall types. The only variables 







Another shortcoming is the fact that the coronary phantoms were scanned stationary and thus, the effect 
of coronary motion was not taken into account in this study. Future studies should be conducted to 
validate our correction algorithm using moving phantoms. However, the current correction algorithm 
could already be applied to other types of vessels where cardiac motion plays no role such as the 
carotids or peripheral vessels. The data used in this study was reconstructed using the most commonly 
used reconstruction kernel in our institution for cardiac CT examination. However, the use of other 
reconstruction kernels may produce different the lumen contrast-enhancement smearing pattern. Future 
validation studies should also cover other variations in experimental settings. 
Conclusion 
Lumen contrast-enhancement influence on the vessel wall can be defined by an exponential 
approximation, allowing correction of the CT density of the vessel wall closest to the lumen. After this 
correction, a more accurate determination of the composition of the vessel wall plaques can be made. 
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Chapter 5 3D Printing and its role in cardiac 
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Although patient specific three-dimensional (3D) visualization already provides good insight in the 
complex anatomy of a patient, in some cases this is not sufficient and more advanced techniques are 
required. Novel techniques for 3D visualization of medical datasets are the use of Virtual and 
Augmented Reality (VR and AR) but also 3D printing could play a major role in this area [1,2]. On the 
one side, 3D printing allows the surgeon to hold and examine the structures printed in a tactile way, 
sometimes providing a better insight in the 3D anatomy. On the other side a real life-size 3D printed 
anatomy allows to test procedures by introducing the actual implants, wires and instruments into the 
printed anatomy. 
The basis of 3D printing was laid in the 1980’s. Medical applications arose from this new technology 
early on in the development mainly in maxillofacial surgery. Although one paper already reported on the 
use of stereolithographic printing of mitral valves based on Ultrasound imaging in patients as early as 
2000 [3], the real interest for 3D printing in cardiovascular applications started some years after that.  
Building on the experience of the early adopters, the past few years have seen an enormous increase of 
the use of 3D printing in a wide variety of medical applications. The field has demonstrated itself as an 
example of multidisciplinary cooperation where radiologists, surgeons, and mechanical/biomedical 
engineers all provide their specific expertise in the different application areas [4]. These application 
areas vary from the printing of anatomical models for teaching and training [5] to models to inform the 
patient about treatment and from pre-operative evaluation of devices to the printing of guides and 
implants used during surgery. In recent years, cardiac anatomy and especially congenital heart disease 
has become one of the focus areas of 3D printing to easily visualize and explore complex cardiovascular 
anatomy. However, other applications that could have major impact on the field of cardiothoracic 
surgery such as planning of transcatheter aortic valve replacement (TAVR) and transcatheter mitral 
valve replacement (TMVR) are also arising. 3D Printing could be used to tackle some of the challenges 
in these interventions such as patient selection, prosthesis choice and sizing, and innovation in valve 
design. In this narrative review, we discuss current state of the art in this area from a technical point of 
view by considering the constraints and possibilities of the 3D printing technique based on published 
work that specifically focuses on 3D printing in cardiac valve disease treatment. We will look at general 






topics such as data preparation, time requirements, printer possibilities, and material properties relating 
to this specific application area. Possible clinical applications from literature will also be introduced. 
 Literature Search 
A PubMed search for English publications with the terms “3D printing” AND “cardiac valve” shows 
that interest in this topic is certainly gaining. Although our initial search resulted in 64 items, after 
analysis of abstracts and text 27 remained valid and related to the review topic. From the references of 
these 27 papers another 7 papers were added resulting in a total of 34 papers. Of these, 5 were earlier 
review papers, of which most only mentioned the specific case of 3D printing in cardiac valve diseases 
as a small sub-section of their review. The selected papers clearly show that about a decade ago the 
interest in 3D printing for this application area was emerging, but only the past 2 to 3 years it really 
gained interest resulting in a steep increase in the number of publications (Figure 1). 
 
Figure 1: Number of publications on 3D printing in the application of cardiac valve assessment or replacement. 









 Source Data and Pre-processing 
To allow 3D printing a high-quality volume dataset with high resolution and no artefacts is required. 
Common modern radiological imaging techniques are able to acquire such data and therefore suitable 
for 3D printing provided that the proper reconstructions and protocols are applied. CT is the most 
common imaging modality providing image data for 3D printing in cardiac valve diseases (18 papers, 
62%) [6-23]. It is followed by Ultrasound (8 papers, 28%) [9, 24-30], computer generated models 
(Computer Aided Design) (2 papers, 7%) [31,32], and MR (1 paper, 3%) [34] (Figure 2).  
 
Figure 2: Frequency of use of source data. 
The quality of printed models is highly depending on the quality of the imaging dataset used. Cardiac 
motion and breathing artefacts have a negative impact on the segmentation and thus the printed volume. 
Typically, high resolution scans are used in combination with electrocardiography gating, breath-hold 
and/or MRI respiratory gating [35]. In order to allow 3D printing of structures, they must have distinct 
tissue contrast in the imaging data [4].  
In CT commonly 0.75 to 1mm slice thickness with a smoother kernel are used [4,6,35]. Higher 
resolution scans are less favorable since they introduce higher noise levels and require a more 
cumbersome segmentation process [35]. Some studies report the use of multiphase acquisition during 






the cardiac cycle to ensure that the right phase can be reconstructed [22]. In MRI, standard cardiac 
imaging sequences can be used. However, the lower resolution of MR in comparison to CT can make it 
difficult to obtain good quality 3D prints [35]. In ultrasound the use of 3D Ultrasound is required in 
order to obtain a proper 3D volume for segmentation of the anatomical structures [24]. 
Regardless of the modality used to acquire the 3D datasets, structures of interest have to be segmented 
and translated into a surface model to enable 3D printing. Of this, segmentation is the key process [33]. 
In some cases, vessel wall is too thin to segment. In these cases, extra thickness should be added to the 
model since 3D printers have minimum thickness requirements [20]. 
The most commonly described tool for segmentation and creation of the STL file required for 3D 
printing is the Mimics/3-Matic software combination (Materialise, Belgium). Secondly, Solidworks is 
also used frequently. Less common are 3D Slicer, AutoDesk Meshmixer and the Vascular Modeling 
Toolkit (VMTK).  
All packages used have in common that they allow to import the (DICOM) imaging data of modalities 
like Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Ultrasound (US) and 
transfer them into a 3D model. This model is realized by segmentation of the structures of interest, after 
which a surface representation is constructed. This surface reconstruction is commonly exported in STL 
format from the modelling software and loaded into the software of the 3D printer. This software allows 
to create and correct the model in order to ensure that it is printable and enables inclusion of required 
structures such as additional support material. After the model is completed, the data is resliced into 
print levels after which it can be sent to the printer to be manufactured.  
 Printing Materials 
Although 3D printing has been around for quite some time already, one of the major areas of concern 
when printing cardiovascular structures such as the aorta, heart, and valves was the limited availability 
of usable printing materials to obtain objects with vessel like properties. Traditional phantoms would be 
constructed with rigid models of resins or glass, but these are not useful when a more life-like 
representation of the vessel wall is required. Therefore, the property requirements of printing materials 
for 3D printing of cardiovascular structures are often concerning the flexibility of the material to mimic 
the vessel wall [11,34] (Figure 3) and the transparent nature of the materials [11] to allow observation of 








Figure 3: Example of RVOT-Main Pulmonary Artery print in flexible, non-transparent material in its normal (a) 
and squeezed (b) form. 
Literature shows that Acrylonitrile Butadiene Styrene (ABS) and TangoPlus FullCure 930 are the most 
commonly used materials (Table 1). TangoPlus FullCure 930 is a commercially available translucent 
rubber-like polyjet photopolymer material. It can simulate different levels of hardness, elongation, and 
tear resistance. Because of the difficulty of direct printing in flexible materials, many papers describe a 
process where they print casts and molds in other materials that are then dipped in or coated with 
silicone to obtain flexible vessels and valves with more accurate tissue properties (e.g. [12,27]. A 
challenge with this method is that it must either be possible to remove the silicone from the cast or mold 
after hardening or the cast or mold should be printed in a dissolvable material. Few examples also exist 











Table 1: 3D Printing materials for intended uses and the application areas. 
Author Intended Use  Application Area Printing Material Post-treatment 
Material 
Abdel-Sayed [11] Training Trans-apical Aortic Valve 
Replacement 
Silicone Silicone Coating 





Fujita [12] Pre-operative 
planning 
Transcatheter Aortic Valve 
Implantation (TAVI) 
ABS Silicone Coating 
Fujita [13] Retrospective 
procedure 
evaluation 





Fujita [14] Pre-operative 
planning 
Transcatheter Aortic Valve 
Implantation (TAVI) 
Photopolymer Resin None 
Izzo [7] Pre-operative 
planning 





Kalejs [31] Device testing Aortic Valve replacement Silicone Silicone Coating 




Mashari [26] Device testing 
 
Mitral valve models 
 




Ripley [20] Pre-operative 
planning 
Transcatheter Aortic Valve 
Implantation (TAVI) 
 
Clear flexible resin 
 
None 
Sardari Nia [27] Pre-operative 
planning 
Mitral valve intervention ABS Silicone Coating 
Vukicevic [9] Training Mitral valve intervention TangoPlus FullCure 
930 
None 
Witschey [28] Pre-operative 
planning 
Mitral valve intervention ABS None 
Owais [29] Pre-operative 
planning 








An additional requirement of specific interest in the case of the cardiac valves is the ability to print with 
multiple types of material to obtain flexible vessel walls and valves in combination with rigid calcified 
plaque deposits. Successful reports have been published using a transparent and flexible material for the 
vessel wall and valves combined with an opaque, rigid material for the calcified plaques [4,7,9,17,19,20] 
(Figure 4). 
 
Figure 4: Example of a print of the aortic valve (a) in flexible transparent material with calcifications in blue non-
flexible material (b). 
For example, Vukicevic et al. [9] 3D printed patient specific mitral valves of 3 patients with multiple 
materials to evaluate trans-catheter mitral valve repair procedures. They did biomechanical tests on 
different TangoPlus materials and compared them with the mechanical properties of the porcine mitral 
valve tissue to select the most appropriate TangoPlus material for specific region of the 3D model. They 
used different TangoPlus materials on different parts of the model in order to have most realistic 
mechanical properties.  
Printing Techniques 
Several printing techniques exist of which most frequently used and well known are Fused Deposition 
Modeling (FDM), StereoLithography (STL), Polyjet and Laser Sintering. Details on these techniques 
have been described extensively in literature [4, 5, 35, 36]. Based on the review performed it is clear that 
STL is the preferred method for cardiac valve printing (40%), followed by FDM (30%). The preference 
for STL can be mainly explained by its ability to print more easily with flexible and transparent 
materials than other techniques.  
3D Printing and its role in cardiac valve replacement procedures
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In some cases, a dedicated setup was built to allow less conventional printing materials or printing 
hardware. One example setup in literature was built with a syringe filled with (sanitary) silicone that was 
used to print a semi-transparent, flexible aortic root [31]. Although this was a very cheap solution and 
printing and post processing time of the print were quite long (3h20min to 3 days) a high accuracy could 
be achieved (3.0% error along X and Y axis / 4.1% error along Z axis).  
 Time Constraints 
The current printing process involves the following steps: 
1) Acquisition of the data
2) Segmentation of the anatomical structures
3) Export of the segments to STL
4) Repair and improvement of the STL file
5) Reslicing and preparing for printing (e.g. definition of support materials)
6) Printing process
7) Post-printing (e.g. removal of support materials, silicone dipping, etc).
The time required to go through these steps is not mentioned in all papers and those that do mostly only 
provide a total processing time for steps 2-7 [11,20,24–26,30,34] (Table 2). The reported time span 
ranges from 30 minutes for an FDM print of the mitral annulus [24] to 3 days for a dedicated FDM 
printer with a syringe filled with silicone followed by silicone dip-coating for a simplified heart model 
[11]. Although the printing time is heavily depending on the size and complexity of the structure that is 
printed, experience shows that the most time-consuming steps are 6 and 7. This especially holds in the 
case of molds and casts where extensive post-printing treatment is required with – for example – 
application of the silicone (often with multiple coat dipping) and, hardening of the material. Steps 2-5 
are increasingly supported by dedicated software tools allowing more automation in the process and 







Table 2: Required time for different printed objects with various printing techniques. 
Author Printer Print method Post-treatment Printed object Time 





with silicone Simplified heart model 3 days 
Biglino [34] PolyJet PolyJet None Descending Aorta 12 hours 





with silicone Aortic Root model 3.3 hours 
Mahmood [25] Objet260 Connex PolyJet NA Mitral valve 90 min 
Mahmood [24] Makerbot 
Replicator 2X 
Fused Deposition 
Modeling None Mitral annulus 30 min 
Mashari [26] Makerbot 
Replicator 2X 
Fused Deposition 
Modeling Silicone casting Mitral valve 2-5 hours 
Muraru [30] Formiga P110 Laser Sintering NA Tricuspid Valve 90-120 min 
Ripley [20] Form 1 Plus Stereolithography NA Aortic Root 5 hours 
Owais [29] Makerbot 
Replicator 2X 
Fused Deposition 
Modeling None Aortic annulus 15 min 
FDM: fused deposition modeling, SLT: stereolithography, NA: not applicable 
In general, required time for the whole process of segmentation, data cleaning and preparation and the 
printing itself varies a lot depending on the size of the printed object, the printing technique used and the 
requirement for post-printing treatment.  
 Possible Printing Issues 
One of the issues with 3D printing is the accuracy of the 3D printed object in size and shape. The 
difference between the 3D printed object and imaging modality measurements should be minimal. Using 
current printers and software the print accuracy is high with reported accuracies of a mean difference 
between measurement in CT and of the print of -0.34mm +/- 1.3mm [20] and 0.7mm +/- 0.3mm [30]. 
No significant differences between CT measurement and actual print measurement were found [30]. 
Therefore, with careful design of the printing process it is possible to print models that resemble real 
anatomy and can be used for pre-operative planning. 
Another issue is the removal of the support materials. Different from most other 3D printed models, the 
vascular models are complex in structure and must be hollow in order to gain access to the lumen with 
wires and devices. This can be achieved by either choosing a printing strategy not requiring support 






material (such as binder jetting) or by removing the support material after printing. A soluble support 
material can be used in a multiple material printer. In that case the object usually has to be submerged 
into, for example, water to dissolve the support material [7]. When printing using a method where the 
same printing material is used for both object and support, the challenge is to fully remove all of the 
support material from the printed object manually. In vascular models this can be quite challenging and 
complete removal of internal supports inside the artery structure can be difficult to obtain. Printing with 
supports also requires careful placement of the structure on the printing bed to minimize the negative 
effect of the support structures since support required will be different with orientation of the object 
(Figure 5).  
 
 
Figure 5: Example of a vessel print with support structures. When the vessel is printed in the anatomically correct 
orientation (a) it is running perpendicular to the printing surface and thus a lot of support material is required. 
When re-oriented and printed parallel to the printing surface (b) less support is required. 
 
 
Clinical Application - Training models 
TAVR is a relatively new and fast growing therapeutic approach. Skills required to perform this kind of 
procedures are difficult to obtain and a steep learning curve is perceived. Traditional training methods 







organizations because of ethical considerations. Moreover, the logistics surrounding the use of animals 
or animal materials is rather cumbersome and complicated. A viable alternative can be found in an 
artificial heart model. However, this has a downside that the variation in anatomy is limited and it often 
involves high manufacturing costs. 3D printing could solve this by providing an easy and relatively 
inexpensive method to obtain a wide variation of training samples that can be easily produced and 
replaced.  
The training models vary from simplified heart models [11] or geometrically designed aortic roots [31] 
to advanced flow models using pulsatile pumps allowing a more real-life simulation [5, 17] where 
devices can be introduced and deployed under lifelike conditions (Figure 6). One study described the 
printing of a MR compatible setup to allow scanning of mitral valves of pigs in the natural state [32]. 
They achieved this by designing and 3D printing valve specific mounting materials based on pre-
mortem Ultrasound intra-valve measurements. 
 
Figure 6: Sample schematic setup of an experimental environment to test valves. The 3D printed valve would be 
included in the Valve Implementation part inside the flow loop (blue lines). 
Clinical Application - Pre-operative Planning 
As stated before, recent years have shown an increase in minimal invasive cardiac surgery with the 
advent of procedures like TAVR. One clear advantage of 3D printing is its utilization in pre-operative 






planning of such complex (minimally invasive) cardiac surgery. Subsequently, the largest subgroup of 
the non-review papers (63%) concerns the use of 3D printing for pre-operative planning. Of these, the 
division between mitral and aortic valve replacement is about 50/50.  
When performing pre-operative planning of TAVR, the printed anatomy ranges from only the Aortic 
annulus [19,20] or aortic arch/aorta [15,21,22] to more complex anatomical configurations with different 
anatomical structures in one print including outflow tracts and heart chambers [12-14]. One study even 
not only used 3D printed anatomy of the aorta but also 3D printed stent models [16]. 
The most crucial information for TAVR planning is the prediction of paravalvular aortic regurgitation 
(PAR). In one of the reported studies the authors demonstrate the use of elastic 3D printed model in the 
prediction of PAR. PAR prediction was done by using a light transmission test. The prosthesis was 
inserted into the 3D printed model and the PAR was predicted based on projection of light through the 
left ventricular outflow tract onto a thin film and captured with a digital camera. This correctly predicted 
PAR in 6 out of 9 patients and absence of PAR in 5 out of 7 patients [20].  
Clinical Application - Device testing  
Device testing and development is also an important application of 3D printing. Biglino et al. 3D printed 
models of the descending aorta with same lumen dimension but different wall thicknesses and did 
compliance tests [34]. They used the distensibility knowledge to build a right ventricular outflow tract 
model, which was used to simulate the pulmonary valve replacement procedure for device testing [34]. 
Kalejs et al. manufactured real life size artic root model for testing valved stents [31]. Mashari et al. 
created a 3D model of the mitral valve from 3D US images of a patient who underwent percutaneous 
MitraClip operation. MitraClip operation is a minimally invasive procedure to reduce the mitral 
regurgitation. The model was then deployed in the pulse-duplicator chamber filled with a blood-
mimicking fluid for hemodynamic testing [26]. 
Discussion 
Novel techniques like 3D printing are investigated by different research groups for specific clinical 
questions and they all explore the technical requirements and shortcomings of the technique. While the 
topic is current, the actual clinical benefit of 3D printing yet remains to be proven. However, technical 
developments are ongoing and the implementation of 3D printing for cardiac valve treatment is one of 







replacement introduces additional requirements when printing concerning the material used and the 
nature of the printed structure. This review shows that with the advent of new – flexible and transparent 
– materials and higher accuracy of 3D printers, an accurate representation of the cardiac anatomy can be 
obtained. This 3D printed representation of the anatomy can already be used in a variety of applications 
and especially for training purposes. 
It has been shown that for accurate 3D Printing of anatomy or pathology, correct segmentation is of vital 
importance and although some of the segmentation work is currently automated, the input of experts is 
still needed for validation and correction. Any small mistake in the segmentation process could lead to 
erroneous prints. This could lead to failure of the printing process itself, but also in a 3D printed 
structure that is not accurate and therefore could be harmful to the patient when used for pre-operative 
planning. The segmentation step should therefore be conducted and/or supervised by an expert in the 
anatomy being segmented and quality control of the source data should be in place. Also, the 
segmentation tools should be validated and approved for clinical use. Although the majority of the 
reviewed papers show the use of a validated commercial software tool, may still rely on freeware and 
open-source software which could hamper reliability of the segmentation, 3D model construction and 
thus the printing result. In this review, we aimed to explore the options, challenges, and possibilities of 
the 3D printing in the field of cardiac valve replacement in order to give an insight in the current state of 
the art and development in this specific area of 3D printing. The low number of papers found on this 
topic demonstrates its experimental nature. However, the papers published do show the progress made in 
the past years allowing clinical application. This clinical application is currently mainly in training and 
education but the literature also shows promise for actual patient specific clinical applications of 3D 
printed models. 
Conclusion 
Current technology allows accurate printing of cardiac anatomy in materials that resemble the properties 
of the actual heart and vessels. The application of 3D printing in valve replacement planning could 
therefore provide new insights in many different ways for the different ‘stakeholders’ [33]. It can 
provide better insight in the anatomy and allow pre-operative training for the treating physician [5]. For 
the patient, it can provide more insight in the disease and treatment options [4,35]. For the manufacturer, 
it allows easier pre-clinical testing of new devices or instruments. Finally, for the educator it can provide 
a wide variety of anatomical and pathological examples that would normally be unavailable.  
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The advent of new and improved scanning algorithms for both Computed Tomography (CT) and 
Magnetic Resonance Imaging (MRI) combined with their increased temporal resolution have facilitated 
the ability to measure and visualize blood flow and perfusion in vivo using these techniques[1,2]. 
However, accurate validation is needed to determine the gold standard. Phantoms are commonly used 
for the validation purposes [3,4]. For proper validation and calibration, a controllable system is required 
which mimics the dynamic pumping function of the heart. 
Phantoms are developed using different kinds of pumps to mimic the blood flow[5-7]. However, the 
type of pump used has major impact on its applicability. Laminar flow pumps do not generate a pulsatile 
flow, which is needed to mimic the blood flow through the cardiovascular system [8,9]. When pulsatile 
flow is needed, most of the time commercial pulsatile pumps are used [7,10,11]. 
In this study, we aimed to develop an affordable pulsatile pump and a mock circulatory system in order 
to simulate the blood flow for validation tests and other development purposes such as image processing 
and medical device testing. The prerequisites for an ideal phantom are identified as:  
1) controllable pulsating flow output equal to the human pulse pattern,  
2) The flow pattern of the mimicked cardiac output should be equal to that of a human,  
3) Stroke volume variable between 40 and 120ml/beat,  
4)Heart rate variable between 60 and 170 BPM.  
The developed phantom was tested with a CT scanner. 
The Setup 
The main components of the phantom setup are the measurement box, the pump, the control box, 
pressure and flow sensors. These components are connected together using tubing (Figure 1). The 
phantom pump should create a pulsatile flow through the measurement box. The measurement box has 
an in- and outflow and can contain different vessel/valve configurations or other phantoms. The 
measurement box is the part of the phantom setup that will be placed inside the bore of the CT or MRI 






and thus should not contain any ferro-magnetic parts. Pump and measurement system should allow use 
of blood as liquid as well. 
 
Figure 1: Flowchart for the pulsatile heart phantom. 
 
The pump 
The pump is a piston pump using a linear actuator (L4118L1804-T5X5A50, Nano-tec) to drive the 
piston inside a cylindrical chamber. The linear actuator has a fixed step size of 0.025mm. The movement 
of the actuator will result in a pulsatile, one-directional flow, by placing one-way valves at the inlet and 








Figure 2: The pulsatile pump. 
The cylinder is from one block of aluminum with a cavity diameter of 59.9mm and a length of 101.0 
mm resulting in a maximum volume of the cylinder of 284.6 ml. Because of the size of the piston, the 
limitations of the length of the axis of the actuator and the general construction of the pump, the actual 
working maximum stroke volume of the pump is 110ml. 
The speed of the piston is dependent on the heart rate, stroke volume and flow pattern set using the 
control panel. The volume/step is constant at 0,0704ml, which defines the amount of volume displaced 
with one-step movement of the linear actuator. Using the settings and this constant, the speed of the 
linear actuator (V) is determined using the following formula: 
V[mm/sec]=((Stroke Volume[ml])/(Volume/step[ml])*0.025)/(60/(Heart Rate[bpm] )*1/2) 
The Control Box 
The control box houses all the electronic parts, such as the microcontroller for controlling the system 
and an interface for operating the system. The micro controller (Atmel, AVR 32 Bits AT32UC3C1512) 
connects all the parts of the hardware and ensures the proper operation of the setup. 
A rotary encoder is used to navigate through the menu of the control box. This rotary encoder allows 
selection by rotation and acknowledgement of a choice by pushing on the rotary encoder. The pump is 
activated by a start button. The stop button is a locking button, so once pressed it needs to be released by 
pressing on it again to activate the pump again. This prevents the rapid start and stop of the pump, which 
might lead to damaging the pump. Unauthorized usage is prevented by integration of a key switch. 
Feedback to the user is provided by a four line, twenty characters, Liquid Crystal Display (LCD). This 
display always provides the state of the system on the first line (e.g. start the pump or change heart rate 






setting). The second and third line shows additional information, such as selected heart rate or values 
acquired from the sensors. The fourth line shows the possible action (e.g. menu scroll by ‘<’ and ‘>’). 
When a variable is surrounded with ‘<’ and ‘>’ the value of the variable can be adjusted by turning the 
rotary encoder. 
The correct operation of the stepper motor is checked using position feedback with a 10-turn 
potentiometer on the axis of the stepper motor. This suffices since the motor axis rotates a maximum of 
9.5 turns to fully expand. By measuring the voltage of the potentiometer, the exact position of the piston 
can be derived. This feedback will not be used to create a feedback loop to adjust the cardiac output. But 
it can be used to monitor if the piston is stuck or that the piston is not attached to the axle any more. It is 
also convenient to use during development of controlling the pump. 
The trigger pulse used for synchronizing the pump action with the acquisition of the CT or MR scanner 
is a logic signal between 0.0 and 5.0 VDC. The frequency of the pulse should be equal to the set heart 
rate. When the pulse is logic low the pump is filled with liquid, which represents the diastolic phase. 
When the logic level of the pulse is high the liquid is pumped out, which represents the systolic phase. 
The transition from a low level to a high level, rising edge indicates the beginning of the QRS complex. 
The hardware of the trigger consist of an op-amp configured as differentiator and comparator. The 
trigger circuit uses the signal from the position sensor. When this signal rises the liquid is pumped out 
and while the signal falls liquid sucked in to the pump. The signal from the position feedback is 
connected to the differentiator is used to create a pulse. Since the amplitude of the block signal is not 
between 0.0 and 5.0VDC, a comparator is used. 
Software Design 
The program is designed with a main loop or a menu structure. In this loop it is possible to switch 
between states by rotating the rotary encoder and select the desired state through pushing on the rotary 
encoder. Each of the states in the menu allows the user to control the functions of the system. For error 
handling every state refers to the error state in case of error. The error state disables the pump and let the 
user know what kind of error took place such as turned off key switch voltage drop below the required 
value. 
When the system starts up, the program starts with state zero. In this state all the settings are configured 







state one it is possible to start the pump with the start button. The state is changed in to state five and the 
pump is initialized for correct functioning before the pumping sequence starts. During the pumping 
action, the sensors sample and send the acquired data to a computer. This communication is done via a 
USB connection. User needs to press on the stop button in order to leave the state and to stop the 
pumping action. Then the system goes back to the first state. 
When the program is back in the main loop, it is possible to change the heart rate and stroke volume. 
The desired state needs to be selected by turning the rotary encoder. When the display shows the desired 
state it can be selected by pushing on the rotary encoder. Then the set value can be adjusted again by 
rotating the rotary encoder and it can be saved by pushing on the rotary encoder. The options state 
allows the user to read the values of the sensor without the pumping action.  
Validation Test 
The phantom setup was tested with a CT scanner in order to validate the pulsatile heart phantom (PHP) 
(Figure 3). During the test, water was continuously pumped through the tubes with a heart rate of 70bpm 
and a stroke volume of 68ml. Approximately 20cm before the measurement box, contrast liquid was 
pumped in the tubing. A section of the tubing is scanned with the CT to create the intensity profile of the 
washout. The 3D image and the washout profile are given in Figure 4. The test was successful for the 
given heart rate and stroke volume. It showed that designed pump can create pulsatile flow and the PHP 
can be used to simulate the blood circulation in the circulatory system. However, the goal of adjusting 
the heart rate and the stroke volume could not be achieved. It was caused by the software of the 
microcontroller. 







Figure 3: The testing with Computed Tomography 
 
Figure 4: Result of the test with Computed Tomography. The 3D image of the scanned section of tubing (a) and 











The developed pump for the PHP can create pulsatile flow and the PHP can be used to mimic the blood 
circulation. The pump was connected via tubes to the measurement box, which is placed in the gantry of 
the scanner. In the measurement box, various types of medical devices such as heart valves or stents can 
be placed to conduct quality or development tests.  
A preliminary test was done to test the principle of the PHP system. It was possible to validate the 
measured flow in the CT to the manually measured flow rate in the PHP. Quite some improvements of 
the PHP came up during the test. The two most important modifications were the setup of the flow 
sensor and the driver, which controls the pump. 
The issue with the setup of the flow sensor was that it was located in a shunt tube. The shunt tube had a 
high resistance therefore; hardly any liquid flowed through the shunt tube. To solve this issue, a 
differential pressure sensor can be used to measure the pressure over a shunt tube with fixed hydraulic 
resistance. The flow can be derived from the measured pressure drop. A pressure sensor is used because 
the response time of the flow sensor was too slow to measure the flow pattern accurately as function of 
time 
The issue with the driver was that the signal required for the driver was created by the microcontroller. 
In the same time, the microcontroller had to drive the pump simultaneously. This resulted in wrong 
values and incorrect driver signals. To solve this issue a separate microcontroller can be used to drive 
the pump independent from the main microcontroller. 
Conclusion 
A principle of proof is given for a heart phantom pump to adjust and measure dynamic flow as a 
validation tool for flow measurement in MRI and CT. This is confirmed with a test in a CT. However, a 
significant a number of improvements should be incorporated to let the PHP operate as initially 
specified. With these improvements, the PHP will be a challenging tool for validation of flow in imaging 
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Aortic stenosis (AS) is the most common valvular heart disease in the developed countries, affecting 3 
percent of the population older than 65 years. It causes higher morbidity and mortality than any other 
cardiac valve disease [1]. AS is defined as narrowing of the aortic valve opening, which reduces blood 
flow from the heart into the aorta. The normal size of the aortic valve area (AVA) at maximum opening 
of the valve is 3 to 4 cm2 [2]. When the AVA decreases below 1 cm2, AS is considered to be severe [3]. 
For severe AS, valve replacement is the only effective treatment. However, a sizeable fraction of 
patients are at high risk for postoperative mortality and may refuse surgery or cannot undergo surgery 
due to comorbidity [4]. Recently, transcatheter aortic valve replacement (TAVR) techniques have been 
developed to provide less invasive treatment for those patients[5-11]. In management of AS, the timing 
for surgical treatment is very important. Late treatment may lead to an increase in the trans-aortic 
pressure gradient, myocardial pressure overload and eventually to left ventricular (LV) hypertrophy and 
increased LV wall thickness [12]. Visualization of the AVA is used to determine the threshold for 
invasive treatment and to obtain preoperative information about the aortic dimensions and proximity to 
other important structures such as the coronary arteries. 
Different imaging modalities have been used and compared for measuring the AVA[13-23]. Initially, 
catheterization was the standard method for evaluating AVA, but in time its usage decreased due to its 
being an invasive modality and technical limitations. Alternatively, the 2D echocardiographic continuity 
equation, which currently is the most common tool to derive the AVA, was used to measure the AVA. 
However, this technique underestimates AVA since it assumes that the left ventricular outflow tract 
(LVOT) has circular geometry, and that flow through the LVOT is laminar and uniform [24, 25]. Bruder 
et al. showed a strong correlation between the AVA determined by echocardiography and MRI [20] 
indicating that MRI can also be used to determine AVA. However, MRI is contra-indicated for patients 
with metal implants or claustrophobia. Moreover, MRI has lower spatial resolution in comparison to CT 
[12]. More recently, development of ECG-gated Multi Detector Computed Tomography (MDCT) has 
led to further improvements in cardiac imaging [21], and CT is now regarded as a reliable method to 
measure the AVA [26]. The latest developments in dual source and 320-slice CT enable high temporal 
resolution acquisition and obtain sufficient image quality at high spatial resolution in almost every 
patient throughout the cardiac cycle. However, streaking and blooming artifacts due to heavy 






calcification of the aortic valve leaflets or the aortic root that hamper visualization and analysis of the 
AVA can still occur.  
Delgado et al. suggested that 3D planimetric measurement of the AVA by MDCT images might provide 
more reliable information on the assessment of AVA in comparison with echocardiography [27]. 
However, planimetric measurement of AVA is currently performed manually by the radiologist using 
standard 3D visualization and measurement software, which is time consuming and introduces user 
dependence and intra- and inter-observer variability [28].  
The aim of this study was to develop and validate a (semi) automatic segmentation technique of the 
AVA and to compare manual and semi-automatic measurements with the Transthoracic 
Echocardiography (TTE) results. Our goal is to reduce the user dependency, time spent on 
measurements, and to enable reproducible and accurate measurement of AVA on MDCT datasets. 
Materials and Methods 
Experimental Design 
In this study multiphase CT scans of 25 patients (15 female, mean age 82.84 ±5.16 years) were used. All 
of the patients had moderate to severe aortic stenosis and underwent TAVI at a tertiary referral center. 
All subjects underwent CT scanning and TTE.  
Informed consent requirement was waived by the local IRB because of the retrospective nature of this 
study without additional burden to the patients involved. 
The maximum aortic valve opening phase was selected visually for all patients. A stack of reformations 
was obtained after centering the axis of the multiplanar reconstruction (MPR) at the level of aortic valve 
and then changing the orientation of the plane perpendicular to the LVOT. The pre-selected slices were 
segmented both manually and semi-automatically by two independent observers 1, a biomedical 
engineer with more than 5 years experience and 2, a cardiac radiologist with almost 10 years medical 
imaging experience. Observer 1 repeated the measurement 1 day after in order to determine intra-
observer variability. Manual and semi-automatic measurements were compared with the current 
reference standard Trans Thoracic Echocardiography (TTE) with regard to AVA. Time spent for 








TTE was performed as part of the routine work-up of the patient. TTE derived AVA measurements were 
obtained from the clinical patient records. The velocity in the left ventricular outflow tract and at the 
level of the aortic valve as well as the LVOT diameter were measured. From these measurements, the 
AVA was calculated using the continuity equation. 
Multi Slice Computed Tomography 
Image acquisition of the retrospectively ECG-gated CTA of the thoracoabdominal aorta was performed 
on a multidetector 256-slice CT (Brilliance iCT, Philips Healthcare, Best, The Netherlands). An ECG 
trace was recorded during the procedure. The region of acquisition ranged from above the aortic arch to 
the groin. Based on a locator image, a circular region of interest was drawn within the descending aorta. 
Non-ionic iodinated contrast material (Ultravist, 300 mg iopromide per mL, Schering Nederland BV, 
Weesp, The Netherlands) was injected intravenously. As soon as the descending aorta reached a density 
of 125 Hounsfield units (HU) within the region of interest, the patient was instructed to maintain a 
breath hold. Seven seconds later, image acquisition started in a craniocaudal direction with concurrent 
ECG trace recording. The following parameters were used: detector collimation 128 × 0.625 mm; pitch 
0.30; matrix size 512 × 512. Tube voltage and tube current–time product depended on the patient’s 
weight and were 100 kVp and 300 mAs, respectively for patients <70 kg, and 120 kVp and 250 mAs, 
respectively for patients ≥70 kg. 
AVA Segmentation Algorithm 
The segmentation algorithm (Figure 1) starts with the detection of the Sinus of Valsalva (SOV) on the 
MPR image. Once the SOV is detected, the region covering the SOV is cropped from the whole image 
(Figure 1a). The cropped image (Figure 1b) is binarized by adaptive thresholding (Figure 1c). The user 
places seed points (Figure 1d) to create an initial contour (Figure 1e) covering the aortic valve opening. 
The contour moves towards the edge of the aortic valve opening automatically (Figure 1f). The contour 
covers the pixels from the edge of the opening area and also the AVA opening area. The pixels of the 
opening area are selected and the number of pixels is multiplied by the pixel size to determine the AV 
opening area (Figure 1g). 






































Detection and Cropping of the Sinus of Valsalva 
Image cropping was used to reduce computation time. In the object detection the object size, shape, 
location and orientation play major roles. Since the SOV is located in the central part of the MPR image, 
detection and cropping of this region begins with a preliminary cropping operation, which covers the 
most of the central part of the MPR image. After the initial cropping, the gray scale image is binarized 
using global thresholding with a threshold level based on the histogram of the image. The binary image 
contains only white (object) and black (background) pixels, which enables detection of the objects in the 
image and facilitates the use of morphological operations. Following binarization, objects smaller than 
700 pixels were removed. Secondly, the SOV was disconnected and isolated. The SOV is located in the 
central part of image, such that objects on the border of the image were removed. After detection of the 
SOV, the region covering it was cropped from the image (Figure 2). All following operations were 
performed on the cropped image. 
Initial cropping
Binarization
Removal of small objects
Isolation of sinus of 
valsalva
Removal of objects on 
the image borders
Locate the objects
Choose the object 
closest to the center of 
image
Crop the region covering 
sinus of valsalva  
Figure 2: The flowchart of the SOV detection and cropping algorithm 






Segmentation of AVA 
The flowchart in Figure 3 shows the details of the segmentation of the AVA. The main segmentation 
tool is the gradient vector flow (GVF) snake (29). The snake algorithm is an active contour, which 
moves to the edges of the object in order to reach the boundaries of the object. In the binarized images 
(described above) the edges are clearer and the active contour can move towards the object boundaries 
easier compared to gray scale images. The user places three seed points on the grayscale image where 
the cusps are connected to each other to create the initial contour for the GVF snake. This initial contour 
creates a mask image, which is used on the binarized image. The active contour shrinks to cover the 
AVA region. However, the GVF snake result overestimates the AVA. Therefore, this GVF snake 
contour is used to mask the image again. In case the resulting double-masked image contains more than 
1 object, the size and location of these objects were determined. Objects smaller than 40 mm2 and the 
object most distant from the center were removed. The remaining object was identified as the AVA. 
Placement of  the 
seed points and 
tirangular initial 
contour created




Masked  image 1
GVF 
Snake
Masked  image 2
Eliminate objects based 
on size and location
Yes
AVA segmented
Mask  image 1 




Figure 3: The flowchart of the AVA segmentation algorithm 
Detection and Removal of Calcification 
Aortic valve calcification is very common in a population with AS. In order to segment the AVA 
properly one must first detect the calcifications and then exclude the calcified areas from the AVA 
region. Since a contrast agent was used in the CT scans we cannot use the fixed 130 HU threshold to 
detect pixels in calcified areas. We therefore developed an algorithm to determine the threshold of 







1. Calculation of the histogram (Figure 4) and determination of the index number (index) of the 
maximum pixel intensity (imMax). 
2. Calculation of the maximum histogram value (MaxH). 
3. Decreasing the index until reaching MaxH/3 and setting the corresponding intensity level as the 
initial estimation (Tcalcest) for calculation of calcium threshold (Tcalc). 
4. Determination of the dynamic range of the image: 
• Starting from the first bin of the histogram, the amount of pixels in each bin was counted until 
reaching half of the total number of pixels. 
• The index number of the histogram bin where the algorithm stopped corresponds to the dynamic 
range (DR) of the image. 
5. Calculation of the calcium threshold (Tcalc) for DR>0.7* imMax (brighter images) by equation 









Figure 4: The histogram of the gray-scale image. 
Semi-Automatic, quantitative, measurement of the calcified and non-calcified Aortic Valve Area using CTA
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An example is given in the Figure 5. The calcified pixels on grayscale image (Figure 5a) are detected 
and given a blue color (Figure. 5b). 
a b
Figure 5: Example of the calcium detection algorithm. 
Computation Time 
Computation time was defined as the time between the visualization of the final cropped image and the 
display of the measurement of the AVA size. For manual measurements it included the time required for 
the user to trace the orifice perimeter and the calculation of the selected area. For the semi-automatic 
measurements it included the selection of the seed points by the user and the computation of AVA based 
on the semi-automatic segmentation results. The time was measured internally by the developed 
software tool and displayed when the AVA size measurement was finished. 
Validation and Statistical Analysis 
Relative differences between the measurements were calculated to determine 1) the intra-observer 
variability of the semi-automatic measurements, 2) the intra-observer variability of the manual 
measurements. Relative difference was calculated as follows:  
Relative difference= Absolute difference *100/mean of the measurements 
Differences between TTE and MDCT manual and semi-automatic measurements were assessed by 
Bland-Altman Plots. Statistical analyses were performed using IBM SPSS Statistics version 20.0.0.1 
(SPSS Inc, Chicago, USA). 
Results 
Segmentation Results  
Aortic valve areas as measured manually and semi-automatically are listed in Table1. Sample results of 







achieved successfully for both calcified (Figure 6. a,b,d) and non-calcified aortic valves (Figure 6c). The 
output result of a segmentation and computation time for a sample image is given in Figure 6e showing 
one part of the graphic user interface. 
Table 1: Manual and semi-automatic AVA measurements 
AVA measurement types  Mean ± SD 
Observer 1 Manual measurements (cm2 ) 0.88±0.23  
Observer 1 Semi-automatic measurements (cm2 ) 0.85±0.15 
Observer 2 Manual measurements (cm2 ) 0.98±0.29 





Figure 6: Results of semi-automatic measurements on various images (a-d), Result on graphic user interface (e). 
Computation Time 
The computation times of both observers were shorter for the semi-automatic measurements. Manual 
measurements took 18.85±5.66 seconds and 16.69±3.69 seconds for observer 1 and observer 2 
respectively. Semi-automatic measurements were 5.06±0.72 (observer 1) and 6.68±1.79 seconds 
(observer 2). 







Differences in intra-observer variability of manual and semi-automatic measurements are listed in Table 
2. Both intra- and inter-observer variability were lower for semi-automatic measurements 
Table 2: Observer variability 
 Observer variability types Relative difference (%) 
Intra-observer variability Manual 8.4±7.1 
Intra-observer variability Semi-automatic 5.8±4.5 
Inter-observer variability Manual 27.6±16.0 
Inter-observer variability Semi-automatic 16.8±12.7 
 
Comparing Manual and Semi-automatic measurements with TTE 
Comparison of the manual and semi-automatic measurements with TTE results were performed using 
Bland Altman plots; mean difference between TTE and MDCT results was -0.19(95 % CI:-0.74 to 
0.34)cm2 for manual, and -0.10(95 % CI:-0.45 to 0.25)2 for semi-automatic measurements (Figure 7 
and 8). The differences were significantly different from 0 (p=0.001 for manual and p=0.007 for semi-
automatic measurements) indicating a bias. Both mean difference and the confidence interval are smaller 
in the comparison of TTE and semi automatic measurements which indicates that semi-automatic 








 Figure 7: Bland-Altman plot between the TTE and manual AVA measurements 
  
Figure. 8: Bland-Altman plot between the TTE and semi-automatic AVA measurements 







Research Summary  
In this study we propose a semi-automatic segmentation technique to measure the AVA and compared it 
with the manual segmentation using TTE measurements as the reference standard. The focus of the 
study was to investigate whether the repeatability and reproducibility of the AVA measurements can be 
improved with the semi-automatic segmentation along with an improvement in computation time. First 
of all, our results show that semi-automatic measurements are closer to the reference TTE 
measurements. Furthermore, the intra- and inter-observer variations are lower for the semi-automatic 
measurements compared to manual measurements. Finally, semi-automatic measurements are more than 
10 seconds faster than the manual measurements.  
Previous Studies and Current Study 
TTE is currently the most widely used imaging modality to measure the AVA. The continuity equation, 
which is used to calculate the AVA based on 2D TTE data, assumes that the LVOT has a circular shape. 
A recent study showed that this assumption might cause underestimation of the AVA [30]. TTE was 
compared to CT in several studies. Larsen et al. observed 6% and 16% intra- and inter- observer 
variability for MDCT measurements on patient with broad severity of AS. Meanwhile the intra- and 
inter- observer variability was 13% and 19 % for the TTE measurements [31]. In our study, the inter-
observer variability of semi-automatic measurements was 16 % in the measurements on the patients with 
severe AS. Lembcke et al. conducted a study with 160 patient using 64- MDCT and TTE. They found 
0.17 ± 0.24 cm2 mean difference between MDCT and TTE measurements [32]. The mean differences in 
the comparisons of TTE with manual and semi-automatic MDCT measurements were 0.19 ±0.27 cm2 
and 0.10±0.18 cm2 respectively. 
Even though (semi)automatic quantification of the aortic root dimensions such as aortic annulus, sinus 
of valsalva and sinotubular junction using CT data has already been available in the literature [33] there 
is a paucity of data about (semi) automatic quantification of the AVA using CT images. Previous 
research already showed that echocardiography underestimates the AVA and CT planimetric 
measurements are closer to the real AVA. Moreover, CT is the modality used for measuring the aortic 
valve calcium score which associated with AS. All of these reasons make CT the method of choice. 







dependent and time consuming. Our results demonstrate the feasibility of developing an algorithm for 
semi-automatic quantitative measurements of AVA in order to reduce observer variability and the time 
spent on the measurements. Moreover, this technique is shown to also work on the target population of 
AS patients with a significant calcium load. The calcified regions should be detected and the opening 
area should be segmented excluding the calcified area. A calcification threshold is needed in order to 
detect the pixels belonging to the calcified region. However, in virtually all CT scans made for pre-
operative evaluation in patients with aortic stenosis a contrast agent is injected which makes impossible 
to set a fixed calcification threshold. To overcome this issue, an algorithm was developed to calculate 
the calcification threshold for each CTA image individually. 
The ultimate goal of fully automatic user independent segmentation was not achieved and user selection 
of three seed points is still required in the semi-automatic segmentation. Main reason for this is that the 
image quality with the current CT technology does not allow making the AVA segmentation fully 
automatic due to unclear object (AV) boundaries in some cases. The GVF snake was the method of 
choice since the snake algorithm works in cases where some parts of the object boundaries are not clear. 
A possible solution to make the segmentation less user dependent could be to develop an algorithm 
which can detect parts of the AVA boundaries (semi) automatically and interpolate the rest of the object 
boundary. Further developments in CT technology with higher spatial resolution and less calcium 
artifacts might also help to achieve the goal of fully automatic segmentation of the AVA. Our results 
show that CT based AVA segmentation can be achieved with less user dependence and as a result a 
higher reproducibility and less time-consuming measurements of AVA segmentation was obtained.  
Limitations 
A possible limitation of our study was that the users were not asked to re-choose the phase and opening 
plane on which to measure the AVA. However, this choice was made to eliminate the user interference 
in the measurement results in order to really test the accuracy of the developed algorithm. Another 
limitation of this study is the selected patient group. We studied a relatively small sample of patients 
with varying delay between TTE and CT imaging and all subjects had severe AS (mean AVA smaller 
than 1.0 cm2.). Future work will have to be carried out in larger cohorts containing subject with varying 
degrees of AS. Also, we cannot rule out that differences in AVA can be attributed to differences in area 
over time as opposed to difference inherent to the imaging techniques used. The time difference between 
the CT and Ultrasound measurements was more than 100 days for 6 patients. A final limitation is having 






2 different measurement techniques using the TTE and MDCT data. In MDCT measurements we had 
the direct measurements using the planimetric image of the AVA on the other hand AVA was measured 
indirectly by the flow information gathered by the TTE. This difference between the measurement 
techniques led to the variation between the TTE and MDCT manual and semi-automatic measurements. 
Therefore, further work required to determine what the clinical follow up should be based on MDCT 
measurements.  
Implications 
Studies comparing the use of CT and echocardiography found that CT can be an alternative to the 
current gold standard echocardiography in the quantification of AVA (26, 27). Our study has some 
implications in semi-automatic quantification of AVA on the CT images. First of all the intra- and inter 
observer variability of semi-automatic measurements are better than the manual measurements. These 
results imply that the variation caused by the user interaction is decreased by using the semi-automatic 
software, which is desirable for quantitative assessment of medical images. Moreover, semi-automatic 
software provides a faster calculation of the AVA in comparison with the manual measurements. Faster 
measurements decrease the workload. The comparison of manual and semi-automatic CT measurements 
with the current standard TTE measurements revealed that semi-automatic measurements are closer to 
the TTE measurements. If the standard modality for measuring the AVA will switch from 
echocardiography to CT, semi-automatic measurements can serve as a better option in comparison to the 
manual measurements due to the smaller difference between the TTE and semi-automatic 
measurements. 
Conclusion 
In this study, a semi-automatic segmentation technique that can be used in AVA segmentation is 
proposed. Based on preliminary results the algorithm provides adequate segmentation of representative 
images also those including severe calcification and provides a faster, more accurate and more 
reproducible AVA segmentation compared to the currently used manual segmentation. 
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In the elderly, the prevalence of moderate-to-severe aortic stenosis (AS) is ~3%.[1] About half of all 
patients with severe AS are referred for surgical aortic valve replacement (AVR).[2] For selected high-
risk patients, transcatheter aortic valve implantation (TAVI) has become a successful alternative to 
conventional valve surgery.[3,4] 
In conventional AVR, the appropriate size of the prosthesis is determined by direct measurements of the 
annulus during surgery. In TAVI, assessment of the annular and prosthetic size relies entirely on 
preprocedural and/or periprocedural imaging. Precise aortic root measurement is essential for choosing 
the correct prosthesis size to minimize the risk of complications such as significant (.mild) paravalvular 
regurgitation, which has been reported in 1–39% of TAVI patients.[5 – 7] Measurements of the aortic 
annulus were originally performed using transthoracic or transesophageal two dimensional 
echocardiography (TTE and TEE, respectively). However, studies have found the aortic annulus to often 
have an ellipsoid shape rather than a circular structure.[8–10] Hence, three-dimensional 
echocardiography or computed tomography (CT) allows for more accurate assessment of the shape and 
size of the annulus by providing images in any desired imaging plane. 
The ascending aorta is known to undergo conformational changes during the cardiac cycle.[11,12] 
However, no consensus exists whether such changes are also present in the aortic annulus and in what 
way. If the annulus does undergo significant dynamic changes, this may affect selection of the most 
optimal cardiac phase for measurement and improve prosthesis sizing or even prosthesis design. In order 
to clarify this concern, we conducted a systematic review of all the literature investigating the dynamic 
behaviour of the aortic annulus using echocardiography, CT, and/or magnetic resonance imaging (MRI). 
Methods 
Literature search 
PubMed and Embase databases were systematically searched on 25 June 2014 using the search syntax 
presented in the Appendix. In Embase, we included only articles, articles in press, reviews, and short 
surveys. No other limitations were applied. Two reviewers (D.S., V.T.) screened all titles and abstracts 
independently. In total, 5637 articles were found and 2173 duplicates excluded manually (Figure 1). 







Figure 1: Literature search 
Article selection 
Only articles aimed at imaging and evaluation of the aortic annulus were included for further screening. 
In total, 146 articles were selected for full text screening. Both reviewers independently excluded studies 
evaluating the annulus only in one cardiac phase and articles on other aortic/cardiac dimensions than the 
annulus. Furthermore, studies on animals, case reports, reviews, editorials, and non-English articles were 
excluded (Figure 1). A third reviewer (R.B.) settled discordant judgements. Our selection comprised 25 
articles on aortic annulus change during the cardiac cycle. References and citations were screened for 







annulus as defined in the search syntax was not mentioned in the title/abstract. The final selection 
included 29 articles. 
Data extraction 
We extracted the following data from the selected articles: first author, journal, publication year, number 
of patients, mean age, gender, number of patients with AS, definition of AS and mean aortic valve area, 
imaging modalities used for measurements including selected plane and imaging phase, definition of 




Twenty-nine original articles were included published from 2001 to 2014. Of these, seven evaluated 
annular dynamic changes in healthy subjects (e.g. no aortic root or valve disease), 10 compared a 
healthy population with AS patients and 12 studies included only AS patients. In total, 2021 subjects 
were evaluated with a mean age ranging from 11±3.6 to 84.9±7.2 years. Study and patient 
characteristics are summarized in Table 1. 
Table 1: Study characteristics 
     No aortic stenosis   
Author, country (ref) Year Patient population N Patients Mean age ± SD 
N Males 
(%) 
Burman, UK (18) 2008 Healthy subjects 120 49.3 ± 17.2* 60 (50%) 
de Heer, Netherlands (10) 2011 CAD screening  108 56.1 ± 12.5 89 (82%) 
Kazui, Japan (20) 2006 Normal aortic root/valve 25 60.1 ± 14.8 17 (68%) 
Martin, France (31) 2013 Cardiac murmur/pre chemotherapy 30 11 ± 3.6 NA 
de Paulis, Italy (13) 2001 Normal aortic root/valve 7 45.3 ± 19 6 (86%) 
Veronesi, Italy (16) 2009 Normal aortic root/valve 24 54 ± 20 7 (29%) 
Zhu, China (21) 2011 Healthy subjects 314 37.2 ± 13.5 
133 
(42%) 
de Heer, Netherlands (24) 2012 CAD screening vs TAVI indicated 15 53 ± 12 12 (80%) 






Hamdan, Israel (33) 2012 CAD screening vs TAVI indicated 11 56.2 ± 11.8 5 (45%) 
Izumi, Japan (22) 2012 Pre AF ablation vs AS 37 68 ± 5 10 (27%) 
Otani, Japan (43) 2010 TEE indicated non-AS vs AS 80 70 ± 10 43 (54%) 
Shabestari, Iran (32) 2013 CAD screening vs aortic calcification 52 50.5 ± 11.3 27 (26%) 
Shiran, Israel (14) 2009 TEE non-AS vs AS 30 62 ± 13 18 (60%) 
Tops, Netherlands (8) 2008 CAD screening no/mild AS vs AS 150 54 ± 11‡ 
111 
(66%)‡ 
Tsang, USA (26) 2013 Stroke work-up vs TAVI indicated 16 80 ± 5 7 (44%) 
Tsang, USA (15) 2013 Normal valves vs AS 20 59.2 ± 17 10 (50%) 
Yoshikawa, Japan (23) 2013 Stroke work-up vs AS 40 65.1 ± 11.7 24 (60%) 
Bertaso, Australia (17) 2012 TAVI indicated - - - 
Blanke, USA (35) 2012 TAVI indicated - - - 
Bolen, USA (27) 2012 TAVI indicated - - - 
Jilaihawi, USA (25) 2012 TAVI indicated - - - 
Kempfert, Germany (44) 2012 Pre conventional AVR - - - 
Lehmkuhl, Germany (28) 2013 TAVI indicated - - - 
Lehmkuhl, Germany (34) 2013 TAVI indicated - - - 
Masri, USA (42) 2014 Pre TAVI or conventional AVR - - - 
Peng, China (36) 2012 Severe AS - - - 
Pontone, Italy (29) 2011 TAVI indicated - - - 
Willson, Canada (30) 2012 TAVI indicated - - - 
Wood, Canada (19) 2009 TAVI indicated - - - 
* Of male subjects 
† Of total group (n=52) 
‡ Of total group (n=169) 
§ 2D speckle tracking echocardiography 







¶ Of total group (n=120) 
AVA(i)= aortic valve area (indexed); AS= aortic stenosis; CAD= coronary artery disease; CT= computed tomography; NA= not 
available;  
HU= CT Hounsfield units; MRI= magnetic resonance imaging; PG= pressure gradient; SD= standard deviation; 
TAVI= transcatheter aortic valve implantation; TEE= transesophageal echocardiography; TTE= transthoracic echocardiography 
  




Aortic stenosis           
N patients Mean age ± SD N Males (%) Definition stenosis AVA (cm2) Mean gradient Imaging 
- - - - - - MRI 
- - - - - - CT 
- - - - - - CT 
- - - - - - 
TTE-2D-
3D 
- - - - - - TEE-2D 
- - - - - - TEE-3D 
- - - - - - TTE-2D 
20 81 ± 6 6 (30%) not defined NA 39 ± 14 CT 
35 80.1 ± 7.4 16 (46%) not defined NA NA CT 
23 73 ± 5 10 (43%) not defined NA NA TTE-3D 
71 73 ± 8 41 (58%) not defined 1.1 ± 0.4 38 ± 20 TEE-3D 
30 66.58 ± 8.90† 30 (58%)† aortic valve calcifications >100 HU NA NA CT 
20 78 ± 9 5 (25%) not defined NA NA 
TTE-2D, 
TEE-2D 
17 54 ± 11‡ 111 (66%)‡ moderate to severe AS 0.8 ± 0.2 50 ± 21 CT 
27 82 ± 7 16 (59%) AVA <1.0cm2, mean PG>40mmHg 0.7 ± 0.1 40 ± 12 TEE-3D 
20 72 ± 9 14 (70%) AVA <1.0cm2, mean PG >40mmHg 0.9 ± 0.2 47 ± 11 TEE-3D 
40 69.3 ± 9.6 25 (63%) AVA <1.0cm2 or PG>40mmHg 0.8 ± 0.4 43.2 ± 18.4 TEE-2D§ 
59 82.4 ± 5 29 (49%) AVA <1cm2, AVAi <0.6cm2/m2 0.73 ± 0.2 NA CT 
110 82.9 ± 7.9 27 (25%) severe AS 0.69 ± 0.18 43.6 ± 14.1 CT 
47 78 ± 9.5 25 (53%) not defined 
CT: 0.93 ± 
0.24 NA CT 
20 84.9 ± 7.2ǁ 50 (52%)ǁ not defined NA NA CT 










Two-dimensional echocardiography (TTE and/or TEE) in systole and diastole was performed in six 
studies, all using the parasternal long-axis view. Three-dimensional modalities used for assessment of 
the annulus were echocardiography (6 studies), MRI (1 study), and CT (17 studies). The CT acquisition 
protocol comprised retrospective ECG-gating in 15 studies, wide-window (20–90%) dose modulated 
prospective ECG-triggering in one study and one study did not specify the CT protocol. Of all three-
dimensional modality studies, the MRI and four CT studies evaluated coronal and/or sagittal plane 
reconstructions[8,10,17 – 19] and one CT study used an undefined longitudinal view.[20] Reconstructed 
double oblique images in plane with the aortic annulus were evaluated in 19 studies. Since the annulus is 
not a true anatomical structure, the exact location of anatomical measurements had to be specified. The 
aortic annulus was defined in general as a virtual ring at the lowest, most caudal, insertion of the valve 
leaflets in 22 studies. Two studies measured the ventriculo-arterial junction [20,21] and five studies did 
not specify aortic annulus.[8,13,18,22,23] Annular measurements were performed semi-automatically in 
six studies[15,16,23 – 26] and manually in the remaining 23 studies. 
Deformation during the cardiac cycle 
On parasternal long-axis view, the annulus diameter was larger in systole than in diastole in 9 of 10 
studies (Table 2, largest mean difference 2.9±0.7 mm). Only two studies performed paired T-
tests[14,20] of which one found a significant change for TEE-derived diameter throughout the cycle 
(mean difference 0.3±0.7 mm, P = 0.0005).[14] No significant change was shown for TTE-derived 
diameter measurements. 
TEE-2D 
56 81.6 ± 6.8 16 (29%) severe AS 
90.7 ± 
14.2(mm2) NA CT 
27 82.3 ± 11.2 6 (22%) severe AS NA NA CT 
87 81 ± 10 47 (54%) symptomatic severe AS 0.6 ± 0.1 46 ± 13 CT 
62 68.2 ± 5.9 41 (66%) not defined 0.83 ± 0.17 61.6 ± 20.9 CT 
60 80 ± 8 22 (37%) not defined 0.7 ± 0.2 51.9 ± 15.2 CT 
66 81.4 ± 7.8¶ 57 (48%)¶ not defined 0.68 ± 0.16§ 42.9 ± 16.6§ CT 
19 83.5 NA symptomatic severe AS 0.59 50.7 CT 






Table 2: Parasternal long axis annulus diameter measurements 
 
Author Imaging Cardiac phase measured Systole Diastole 
Mean 
difference P-value 
Patients without aortic valve stenosis         
Kazui (20) CT* 40%, 80% RR-interval 22.5 ± 2.2 22.1 ± 2.2 - NS 
Martin (31 ) TTE-2D mid-systole, end-diastole 19.4 19.5 - - 
de Paulis (13) TEE-2D systole, diastole 22.2 ± 1.6 20.6 ± 1 7% ± 3.2% - 
Shiran† (14) TTE-2D mid-systole, end-diastole 21.1 ± 2.1 21.0 ± 1.8 0.2 ± 0.8 P= 0.2 
  TEE-2D mid-systole, end-diastole 21.6 ± 2.2 21.3± 2.1 0.3 ± 0.7  P= 0.0005 
Yoshikawa (23) TEE-2D‡ 
83 ms, 421 ms from ECG R-
wave 22.9 ± 2.7 20.0 ± 2.9 2.9 ± 0.7 - 
Zhu (21) TTE-2D mid-systole, end-diastole 20.91 ± 2.3 20.35 ± 8.7 - - 
Patients with aortic valve stenosis         
Kempfert (44) TTE-2D end-systole, end-diastole 24.2 ± 3.5 22.9 ± 3.1  - - 
  TEE-2D end-systole, end-diastole 24.5 ± 2.7 23.8 ± 2.7 - - 
Yoshikawa (23) TEE-2D‡ 
99 ms, 435 ms from ECG R-
wave 21.6 ± 2.6 19.4 ± 2.6 2.2 ± 0.6 - 
All annular measurements are presented in millimeters as mean ± standard deviation 
* In CT longitudinal view 
† Results are the same for non-stenosis and stenosis patients 
‡ TEE speckle tracing 
CT= computed tomography; NS= non-significant; ms= milliseconds; TEE= transesophageal echocardiography; 









Results on coronal view measurements were contradictory as the largest annulus diameter was found 
either in the systolic (n = 3) or diastolic phase (n = 3) (Table 3). One study evaluated the mean diameter 
difference between these phases (0.23 mm) but no statistical significance was reached. [17] However, all 
results on sagittal view showed larger systolic than diastolic annulus diameters with significant 
difference (mean 0.42 mm, P = 0.008), though tested only by one study [17] (Table 3). 
Table 3: Coronal and sagittal axis annulus diameter measurements 
 
      Coronal view     Sagittal view     
Author Imaging 
Cardiac phase 
measured Systole Diastole Mean ∆ P-value Systole Diastole Mean ∆ P-value 






2.1 (M)  
26.2 ± 




2.4  - - 

















2.4 - - - - - - 










2.7 - - 








































2.1 - - 






All annular measurements are presented in millimeters as mean ± standard deviation 
(F)= in females; (M)= in males 
Mean ∆= mean difference between systolic and diastolic measurement 
 
Table 4 shows all diameter measurements acquired using the double oblique in plane view. No evident 
pattern was found for change in maximal (long axis) annulus diameter since it was largest either in 
systole or diastole in seven patient groups each. Statistical analysis was performed by seven studies 
[10,17,25,27 – 30] but only one found significant differences (mean 0.3±2.4 mm in diastole, P < 0.001). 
[10] In contrast, the minimal (short axis) annulus diameter was largest in systole in the majority of 
patients (16 study groups) and in diastole in three studies (four patient groups). [22,31,32] The change in 
diameter (Figure 2) was significant in 11 patient groups[10,17,22,25,27,28,30,33,34] all showing a 
greater short-axis diameter in systole except for the two groups of Izumi et al.[22] Pontone et al.[29] did 






Figure 2: Dynamic deformation of the annulus. Cardiac ECG-gated multidetector-row computed tomography 
images reconstructed in each 10% phase of the RR-interval. Note the conformational change of the aortic annulus 
showing a more circular shape during systole and an oval shape during diastole. Whereas the long-axis diameter 





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The annular area was evaluated in 18 patient groups using double oblique plane reconstructions (Table 
5). The majority (n = 15, 83%) showed the largest area during (early) systole, with a maximal mean 
difference of 122±33 mm2 throughout the cardiac cycle. [24] Nine groups were statistically evaluated 
[16,17,24,29,30,33,35] and the area was significantly larger during systole in seven, during diastole in 
one and not significantly different in one group. [29] The annular perimeter was largest during systole in 
five and during diastole in three groups (Table 6). This was tested and significant in four and one patient 
group, respectively. The largest mean difference between systole and diastole was 5.4±1.5 mm. [35] 






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 6: Double oblique plane annulus perimeter measurements 
 
      Perimeter 
Author Imaging Cardiac phase measured Systole Diastole Mean difference P-value 
Patients without aortic valve stenosis         
Hamdan (33) CT all: max 30%, min 90-0% 76.1 ± 6.7 74.1 ± 7.6 2.2 ± 2.2 0.01 
Shabestari (32) CT 30-35%, 70-75% 86.64 ± 7.40 88.12 ± 8.90 1.48 - 
Veronesi (16) TEE-3D all: max 19%, min 57% 69.5 ± 10.6 78.1 ± 11.5 - <0.05 
Patients with aortic valve stenosis         
Blanke (35) CT all: max 20%, min 60% 79.6 ± 6.0 74.2 ± 5.7 5.4 ± 1.5 (7.3 ± 2.1%) <0.001 
Hamdan (33) CT all: max 30%, min 90-0% 78.9 ± 8.7 77.3 ± 8.6 0.56 ± 0.85 0.01 
Masri (42) CT all: max NA, min NA 80 ± 9 77 ± 9 3 ± 1 - 
Shabestari (32) CT 30-35%, 70-75% 86.67 ± 8.52 87.51 ± 8.21 - - 
Willson (30) CT 25-35%, 75% 78.5 ± 8.2 77.2 ± 8.0 - 0.01 
All measurements are presented in millimeters as mean ± standard deviation 
NA= not available 
AS vs. non-stenosis 
As presented in Tables 3–6, both non-AS patients (e.g. without aortic root disease) and AS patients 
showed significant annular change throughout the cycle. Five studies directly compared the extent of 
conformational change between AS and non-AS patients. Based on longitudinal parasternal view 
measurements, Shiran et al. found similar results for AS and non-AS patients. In contrast, Yoshikawa et 
al. detected significantly less absolute and relative diameter change in AS patients (P ≤ 0.0027). [23] 
Furthermore, the diameter reached its maximal value at a later point in the cardiac cycle than in non-AS 
patients (99 vs. 83 ms from the R-wave, resp. P < 0.0004). Using double oblique plane images, Izumi et 
al. also found a significantly smaller annulus diameter deformation in AS patients (2 vs. 8% in controls, 
P < 0.0001). [22] In the study of Hamdan et al., AS patients showed higher annular stiffness compared 







P = 0.029). [33] No significant difference was found for dynamic changes between patients with and 
without aortic valve calcifications. [32] 
Other factors 
Aortic root calcifications in general did not show a correlation with annular change [32] or circularity 
[28] during the cardiac cycle. But the location of the calcifications was related to annulus area change, 
showing the least change with both annular and commissural calcifications (6 mm2) and the greatest 
change with only commissural calcifications (23 mm2). [32] Only one study evaluated the influence of 
age on annulus change within the cardiac cycle but found no age effect. [32] In this study, a weak linear 
correlation was found between diastolic blood pressure and annulus perimeter changes (r = 20.25, P = 
0.01), and between ejection fraction and minimal diameter changes (r = 20.22, P = 0.03). Another study 
found the left ventricular outflow tract diameter and stroke volume to be associated with larger changes 
throughout the cycle. [36] 
Impact on prosthesis sizing 
Blanke et al. evaluated the annulus in 5% steps throughout the full cardiac cycle and found the selected 
cardiac phase to affect prosthesis agreement. [35] Selection of the cardiac phase in which the area or 
perimeter-derived diameter reached its maximal value showed the highest agreement with the selected 
Edwards Sapien prosthesis and most relative oversizing (±10%). The area and perimeter were largest 
between 0 and 30% phases of the RR-interval. Measurements obtained in the clinically used 35%-
systolic and 75%-diastolic cardiac phase showed only 76% prosthesis agreement (84/110 patients) and 
less relative oversizing (±7 and±5%, resp.). [35] In particular, 75%-diastolic phase area and diameter 
measurements led to (theoretical) undersizing in 15 (14%) and 6 (6%) patients. In this phase, the area 
and perimeter-derived diameters differed 2.7±1.4 and 2.0±1.1 mm with the prosthesis compared with 
1.5±1.2 and 1.1±1.2 mm during maximal phase measurements, respectively. Likewise, Wilsson et al. 
found diastolic phase measurements to result in smaller Sapien XT prostheses in 13/66 patients and in 
larger in only 1/66 patients. [30] The patients with downsized prostheses showed significantly larger 
conformational change in annulus diameter, area and perimeter compared with patients without a switch 
in prosthesis size. In contrast, the use of the diastolic diameter in another study resulted in a larger 
prosthesis in 2/34 patients (29 vs. 26 mm Corevalve). [17] Some patients might show the largest area in 
the diastolic phase, as also found by de Heer et al. [24] in 3/15 patients. 
 







This systematic review clearly demonstrates that the aortic annulus does undergo dynamic 
conformational change during the cardiac cycle. The annulus becomes more circular in systole and has a 
predominantly oval shape in diastole. Using double oblique reconstructions perpendicular to the centre 
lumen line of the left ventricular outflow tract the annulus has a significantly larger short-axis diameter, 
area, and perimeter in systole compared with diastole. A greater diameter is also found in systolic 
compared with diastolic phase on the parasternal long-axis and sagittal views, though each was 
statistically confirmed only by one study. In contrast, the double oblique long-axis diameter suggests no 
significant change throughout the cardiac cycle and the same goes for the coronal diameter. 
Results on differences for the magnitude of conformational changes between AS and non-AS patients 
are contradictory. 
The finding that the aortic annulus undergoes conformational changes during the cardiac cycle is 
important and may add to improved prosthesis design. In clinical setting, this knowledge may add in 
selecting the optimal imaging phase and approximating the true annular dimensions. Blanke et al. 
showed better annular agreement with prosthetic sizes selected based on the maximal annular values 
throughout the cardiac cycle compared with prostheses based on routine predefined systolic (35%) or 
diastolic (75%) reconstructions. [35] Importantly, de Heer et al. found the cardiac phase for maximal 
annulus area to vary between patients from 0–60 and 90% of the RR-interval and similar differences 
exist for the minimal area. [24] Apparently, the systolic phase does not represent the aortic annulus in its 
maximal dimensions in all patients. This might also be one of the reasons why some studies found larger 
diastolic diameters and/or no significant differences in the overall patient group. Assessment of the full 
cardiac cycle hence enables selection of the annulus in its ultimate dimensions, which may improve the 
annulus to prosthesis agreement. 
Likewise, the choice of the measured parameter may affect prosthesis size selection as well since the 
annulus, in general, is an ellipsoid structure. The results show the minimal short diameter axis to 
significantly change in dimension, whereas the maximal diameter remains relatively unchanged. In 
addition, the perimeter changes throughout the cardiac cycle as well. These findings support the belief 
that the annular structure becomes less oval throughout the cycle. Studies using a so-called effective 
diameter, the diameter calculated from the measured area or perimeter, may induce an error if solely 







specific patients, for instance, in patients whose annular dimensions are in the overlapping/border zone 
prosthesis size recommendations. Multiphase assessment providing knowledge on the amount of annular 
distensibility may also be helpful in choosing the most optimal size in these patients. 
Furthermore, the change in dimensions of the aortic annulus seems to urge the use of three-dimensional 
techniques for accurate annulus size assessment. An advantage of CT is that it provides an overview of 
the cardiac anatomy and calcifications present which may impact prosthesis size selection in border zone 
patients.[37] TEE might be a helpful three-dimensional modality in patients not eligible for contrast-
enhanced CT imaging. [37 – 39] However, compared with CT measurements 3D-TEE consistently 
displayed smaller dimensions, which may cause significant undersizing. [38,39] Two-dimensional TEE 
showed even more undersizing compared with CT-based sizing.[39] Hence, the use of three-dimensional 
imaging modalities and CT in particular seems indispensable to reduce potential sizing error. 
Patient post-procedural outcome has often been related to the presence of relevant paravalvular 
regurgitation, although the direct association with mortality yet needs to be evaluated.[40] One of the 
key factors in paravalvular regurgitation is the relation with prosthesis oversizing and undersizing. 
[28,30,41] The purpose of this review was to assess whether the aortic annulus undergoes significant 
dynamic change and its possible implications for prosthesis size selection. Currently, TAVI prostheses 
are available in four sizes (23, 26, 29, and 31 mm) for annular sizes of 18–29 mm and the prosthesis size 
recommendations overlap for annulus dimensions. 
Results showed the systolic short-axis diameter to differ significantly by (mean) 0.75 mm minimum [17] 
to 2.7±1.6 mm maximum [33] from the diastolic diameter. Maximal differences within the cycle ranged 
to even 8.7 mm in Peng et al. [36] With little annular change, the impact on TAVI sizing may be small 
as was the case in the study of Bertaso et al.. [17]With greater annular deformations, diastolic sizing can 
lead to a relevant change in prosthetic size selection, as 20% of patients in the study of Willson et al. 
received a smaller prosthesis. [30] The conformational change of the annulus showed to impact the 
annulus to prosthesis agreement, [35] consequently it also may result in (undesired) oversizing or 
undersizing and thus in paravalvular leakage. Remarkably, one study found significantly less 
conformational change of the annulus in patients with clinically relevant paravalvular leakage, showing 
a mean area deformation of 32±10 vs. 46± 21 mm2 (P = 0.003) in non-leakage patients and perimeter 
deformation of 2.6±0.8 vs. 3.6±1.3 mm (P = 0.001), respectively. [42] For paravalvular leakage 
prediction, the same study showed 74% sensitivity and 72% specificity for conformational changes of 






<3 mm in annular perimeter. Prosthesis to annular perimeter size ratio and annular calcifications were 
also independent predictors for paravalvular leakage.  
As shown in this review, results vary remarkably between specific studies. The reported mean 
percentage change ranges from 4 to 28% for area, 2–12% for minimal diameter and 0.56–7.3% 
perimeter. Evidently, the heterogeneity between studies is substantial and likely accounts for the 
observed ranges. Significant differences are present for both study methods and patient characteristics. 
With regard to the first, study sample size and imaging modality may affect study results just like the 
assessment of two predefined vs. all cardiac phases and manual vs. semi-automatic measurements. 
Second, patient age, gender, and degree and/or definition of stenosis differ between studies. The impact 
of gender on the amount of conformational change has not been evaluated and only one study reported 
on the effect of age without significant differences. No consensus exists on whether the annular 
conformational changes vary between AS patients and non-AS patients. Furthermore, patients with 
aortic root calcifications in general did not show significant differences with the control group, whereas 
significant differences were found for annular area related to the distribution of calcifications. [32] More 
research and larger study samples are needed to provide basic insight on various potential factors 
affecting the annular distensibility and conformational changes. As for TAVI sizing and patient 
outcome, it is essential to take the dynamic deformation into consideration by selecting the optimal 
imaging modality, cardiac phase, and annular parameter. Based on this review, we can conclude that 
three-dimensional imaging is required for adequate annulus assessment. Despite its well-known 
drawbacks, CT provides the most comprehensive overview of cardiac structures and optimal imaging 
plane reconstructions and hence allows for reliable assessment of all annular dimensions. The use of 
two-dimensional imaging modalities on the other hand may lead to relevant prosthesis undersizing. 
Furthermore, selection of the cardiac phase in which the annulus shows the largest dimensions seems to 
prevent (theoretical) prosthesis undersizing, but the maximal phase is patient specific. Future studies are 
required to evaluate the effect of the use of different annular parameters on patient outcome and to 
prospectively assess the clinical impact of sizing based on different cardiac phases. 
Limitations 
In this study, we did not take the effect of semi-automatic or manual measurements into account. 
Secondly, variability in the definition of annulus might impact study results, although the majority of 







patient analyses to be able to assess differences on patient level. Lumping the mean overall systolic and 
diastolic diameters reported will not provide the mean difference within patients. Hence, insufficient 
data were available to perform a meta-analysis to acquire the pooled difference for mean change of the 
annulus within the cardiac cycle. Finally, evaluation of the accuracy of annulus measurements using 
different imaging modalities in comparison with true intra-operative measurements was beyond the 
scope of this review. 
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Appendix 
Search strategy performed in PubMeda and Embaseb on 25 June 2014 
1 Imaging OR CT OR CTs OR ‘computer tomography’ OR ‘computed tomography’ OR ‘computerized 
tomography’ OR ‘CAT scan’ OR ‘CAT scans’ OR MDCT OR MSCT OR CTA OR ‘computer-assisted 
tomography’ OR ‘computed-assisted tomography’ OR ‘magnetic resonance imaging’ OR ‘magnetic 
resonance’ OR MRI OR MR OR NMR OR NMRI OR CMR OR echocardiographies OR 






echocardiography OR TTE OR TEE OR ultrasound OR ultrasonographies OR ultrasonography OR 
ultrasonic OR echography OR echographies OR echotomography OR echotomographies 
2 ‘aortic annulus’ OR ‘aortic annular’ OR ‘aortic root’ OR TAVI OR TAVR OR ‘transcatheter valve’ 
OR ‘percutaneous valve’ OR ‘transcatheter aortic valve’ OR ‘percutaneous aortic valve’ 
3 (1 and 2) 
a; In title/abstract. 









Chapter 9 Samenvatting 
Computertomografie (CT) is een van de meest prominente beeldvormingsmodaliteiten in de klinische 
praktijk en klinisch onderzoek. In dit proefschrift worden verschillende toepassingen van CT, waaronder 
3D-modellering, chirurgische planning en diagnose, gepresenteerd met als focus coronaire hartziekte 
(Coronary Artery Disease = CAD) en de aortastenose. Het proefschrift is verdeeld in twee 
hoofdonderdelen, namelijk 1) Coronaire morfologie en plaque, 2) Aortaklepmeting. 
Deel 1 Coronair Morfologie en Plaque 
Deel 1 bevat drie originele studies, waarvan twee onderling verband houden met elkaar. In deze studies 
is gekeken naar de relatie tussen de geometrie van de kransslagaders en CAD. In de eerste studie 
(hoofdstuk 2) werden alleen gegevens uit 1 fase van de hartcyclus (eind diastolische fase) gebruikt, 
terwijl de andere studie (hoofdstuk 3) werd uitgevoerd met gegevens uit zowel de eind-systolische als de 
eind-diastolische fase. In beide onderzoeken waren kromming en kronkeligheid (turtuositeit) de 
gebruikte geometrische maten, die werden bepaald met behulp van een semiautomatisch gegenereerde 
middellijn op de coronaire CT-beelden. De metingen zijn uitgevoerd op vat- en segmentniveau. De 
kransslagadersegmenten werden bepaald op basis van de 15-segment classificatie van de American 
Heart Association. De statische studie (Hoofdstuk 2) toonde aan dat kromming kan worden geassocieerd 
met significante stenose en aanwezigheid zowel op segment- als slagaderniveau, terwijl tortuositeit 
alleen op segmentniveau geassocieerd kan worden met significante stenose en aanwezigheid van plaque. 
Deze studie toonde aan dat op CT-gebaseerde metingen van de kransslagadergeometrie verband houden 
met de aanwezigheid van plaque en significante stenose, waardoor een vroege risicobeoordeling 
mogelijk is. De relatie tussen dynamische veranderingen van de coronaire arterie-geometrie en CAD 
eveneens op basis van CT-beelden (n = 71) werd onderzocht in Hoofdstuk 3. In deze studie werd het 
aantal buigpunten gemeten naast kromming en tortuositeit als een van de geometrische kenmerken. De 
metingen werden uitgevoerd in de systolische en diastolische fasen van de hartcyclus, die waren 
gebaseerd op, respectievelijk, de minimale en maximale vulling van de linker hartkamer. Er was geen 








Het laatste onderzoek (Hoofdstuk 4) van dit deel heeft tot doel een algoritme te ontwerpen en valideren 
om de invloed van lumencontrast op niet-verkalkte atherosclerotische plaque Hounsfield-Unit (HU) -
waarden in CT-beelden te corrigeren om zo CT-beelden te verkrijgen met de juiste HU-waarden voor de 
karakterisering en kwantificering van niet-verkalkte plaques. Voor dit doel zijn speciaal ontworpen 
coronaire vatfantomen gebruikt met ronde, holle lumina met een diameter van 1, 2 en 4 mm. De 
fantomen werden in olie gescand met behulp van een dual-source CT-scanner met zowel vaten met als 
zonder plaque in de vaatwant. De scan werd na een scan zonder contrast middel herhaald met vullingen 
van verschillende verdunningen van contrastmiddel met water (corresponderend met 100-400HU, met 
een interval van 100HU). Pixel voor pixel vergelijking van contrastversterkte en niet-contrastversterkte 
beelden bevestigde het eerder vastgestelde exponentiële vervalpatroon van de HU op de wand 
veroorzaakt door het contrastmiddel. Op basis van dat patroon is een correctiealgoritme opgesteld dat 
werd toegepast op de beelden met contrast. Het algoritme corrigeert voor de invloed van het 
contrastmiddel op het meest aangedane wandgebied, dat zich binnen een straal van 2 pixels vanaf de 
lumengrens bevindt, waardoor het mediane verschil van 45 HU wordt teruggebracht tot een verschil van 
4 HU. Deze correctie maakt een nauwkeurigere bepaling van de vaatwandsamenstelling mogelijk. 
Deel 2 Aorta Klepmeting  
In dit deel worden vier onderzoeken gepresenteerd. De eerste twee hebben betrekking op het modelleren 
van hartklepaandoeningen.  
In een systematische review werden de toepassingsgebieden van 3D-printen in de 
hartklepvervangingsprocedures in kaart gebracht (Hoofdstuk 5). Verder zijn parameters als 
voorbewerking, printmaterialen, printtechnieken, en tijdsdruk onderzocht. Uit het systematisch 
literatuuronderzoek bleek dat CT de meest gebruikelijke beeldvormende techniek is voor 3D printing 
toepassingen. Acrylonitrile Butadiene Styrene (ABS) en StereoLithography zijn, respectievelijk, de 
meest voorkomende 3D-printmaterialen en printtechnieken. Twee belangrijke problemen bij deze 
techniek zijn het verschil in grootte tussen het 3D-geprinte model en de werkelijke grootte van het 
gescande object, en het verwijderen van de ondersteunende materialen van de 3D print. Als klinische 
toepassingen van 3D-printen werden vermeld: 1) het creëren van trainingsmodellen, 2) preoperatieve 
planning en 3) testen van apparatuur. 
De tweede studie in dit deel beschrijft het ontwerp en de validatie van een pulserende pomp en een nep-







fantoomopstelling is gevalideerd door het tijdens het pompen te scannen met een Siemens Sensation 64 
MDCT scanner. De test was succesvol voor een slagvolume van 68 ml bij een frequentie van 70 slagen 
per minuut. De pomp produceert een realistische pulserend stroomprofiel en het nep-circulatiesysteem 
geeft een goede representatie van de bloedcirculatie. 
De laatste twee onderzoeken hadden meer betrekking op de klinische praktijk. Een van deze studies 
behelst het ontwerp en de validatie van een snelle en robuuste semi-automatische segmentatietool om 
het aortaklepgebied (AVA) op CT-beelden te segmenteren (Hoofdstuk 7). Om het algoritme te 
valideren, is de AVA door twee waarnemers handmatig en semi-automatisch gesegmenteerd op 25 CT-
beelden. De metingen werden vervolgens vergeleken met als gouden standaard de op echocardiografie 
gebaseerde resultaten van dezelfde patiënten. Deze resultaten toonden aan dat het ontwikkelde algoritme 
een snelle, nauwkeurige en robuuste manier biedt om AVA te kwantificeren.  
 Hoofdstuk 8 is een systematische review waarin de vraag wordt gesteld: 'Ondergaat de aorta annulus 
tijdens de hartcyclus relevante vorm veranderingen?'. Dit is een belangrijke vraag, aangezien de grootte 
van de aorta-annulus de belangrijkste maat is voor het bepalen van grootte van een implantaat dat zal 
worden gebruikt in de minimaal invasieve transcatheter-aortaklepimplantatie (TAVI) -procedures. 
Fouten bij de selectie van de prothese kunnen leiden tot aortaklepinsufficiëntie of scheuring van de 
aortawortel. Uit het systematisch literatuuronderzoek bleek dat de aorta-annulus ronder is in de systole 
en overwegend ovaal in de diastole. De ringvormige diameter van de lange as vertoonde een niet-
significante verandering gedurende de cyclus, terwijl de diameter, het oppervlak en de omtrek van de 
korte as significant groter waren in systole vergeleken met diastole. Deze resultaten suggereren dat de 
aorta-annulus tijdens de hartcyclus dynamische veranderingen doormaakt en dat meerfasige aorta-
annulusmetingen van groot belang zijn voor TAVI-planning om onder- of overschatting van de 
maatvoering van de prothese te voorkomen. 
Conclusie 
Door de niet-invasieve aard en verbeterde temporele resolutie van CT kunnen nieuwe risicofactoren, 
zoals vaatgeometrie, worden onderzocht om hart- en vaatziekten te voorspellen. Het is tevens de 
belangrijkste medische beeldbron voor het 3D-printen van fysieke anatomische modellen, die kunnen 
worden gebruikt bij medische training, preoperatieve planning en het testen van apparatuur. Naast de 







overschatting van de maatvoering van de prothese te voorkomen om de uitkomst van de minimaal 
invasieve cardiovasculaire procedures te maximaliseren. 
Kortom, CT is de dominante 3D-beeldvormingsmodaliteit, die de klinische besluitvorming ondersteunt 
in de verschillende stadia van therapeutisch beheer van hart- en vaatziekten, van vroege risicobepaling 







Chapter 10 Summary 
Computed Tomography (CT) is one of the most prominent imaging modalities in clinical practice and 
clinical research. In this thesis various applications of CT. including 3D modeling, surgical planning, 
and diagnosis. are presented. The focus was on coronary artery disease (CAD) and the aortic stenosis. It 
was separated in to two main parts namely 1) Coronary Morphology and Plaque, 2) Aortic Valve 
Measurement. 
Part 1 Coronary Morphology and Plaque 
Part 1 includes three original research study two of which are related to each other. In these studies, the 
relationship between the coronary artery geometry and the CAD were investigated. In the first study 
(Chapter 2) only data from one phase (end-diastolic phase) were used, while the other study (Chapter 3) 
was conducted with data from both end-systolic and end-diastolic phases. In both studies, curvature and 
tortuosity were the common geometric metrics, which were quantified using a semi automatically 
generated centerline on the coronary CT images. The measurements were done at artery and segment 
level. The coronary artery segments were determined based on the 15-segment modified American Heart 
Association classification. The static study (Chapter 2) showed that curvature was associated with 
significant stenosis and presence both at segment and artery level while tortuosity was associated with 
significant stenosis and presence of plaque only at segment level. This study showed that CT based 
coronary artery geometry measurements are related to the presence of plaque and significant stenosis, 
which may allow early risk assessment. The dynamic study (Chapter 3) investigated the relationship 
between dynamic changes of coronary artery geometry and CAD using again CT images (n=71). In this 
study, number of inflection points were measured in addition to curvature and tortuosity as one of 
geometric metric. The measurements were done at end systolic and end diastolic phases of the cardiac 
cycle, which were based on the minimum and maximum filling of the left ventricle respectively. In this 
study (Chapter 3), there was no significant association between the change in geometric parameters 
through the cardiac cycle, and severity of CAD. The last study (Chapter 4) of this part is an image 
processing study aimed to construct and validate an algorithm to correct the influence of lumen contrast 
enhancement on non-calcified atherosclerotic plaque Hounsfield-Unit (HU) values in CT images in 
order to obtain the correct HU values for the characterization and quantification of non-calcified 







diameter circular hollow lumina); with normal and plaque-infested walls were scanned simultaneously 
in oil using a dual-source CT scanner. The scan was repeated with water and contrast agent (100-
400HU, at 100HU interval) fillings. Pixel by pixel comparison of contrast enhanced and non-contrast 
enhanced images confirmed the previously determined exponential decline pattern of HU on the lumen 
wall caused by the contrast agent. Based on that pattern a correction algorithm was formulated. The 
algorithm was applied to the contrast enhanced images. Algorithm corrected the lumen contrast-
enhancement influence on the most affected wall region, which is within a 2-pixel radius from the lumen 
border, reducing the median difference of 45 HU to a median difference of 4 HU. This correction 
enables a more accurate determination of vessel wall composition.  
Part 2 Aortic Valve Measurement 
In this part, four studies were presented. First two studies were related to modeling and experimenting in 
the field of valvular diseases. The first study (Chapter 4) is a systematic review investigating the 
application areas of 3D printing in the heart valve replacement procedures. This study further 
investigated the source data and pre-processing, printing materials, printing techniques, the time 
constraints, and the other 3D printing issues. The systematic literature search revealed that CT is the 
most common imaging technique to provide medical image data to create the medical image data. 
Whereas, Acrylonitrile Butadiene Styrene and StereoLithography are the most common 3D printing 
material and printing techniques respectively. Two major issues reported in these studies are difference 
in size between the 3D printed model and real-life size of the object 3D printed, and removal of the 
support materials. The clinical applications of the 3D printing were listed as 1) creating training models, 
2) Pre-operative planning and, 3) Device testing.  
The second study in this part was describing the design and validation of a pulsatile pump and a mock 
circulatory system, which was planned to be used in the software, and medical device validation 
(Chapter 6). The phantom set up was validated with an experiment using a Siemens Sensation 64 MDCT 
scanner. The test was successful for a stroke volume of 68 ml and 70 beats per minute. The pump 
produces a realistic pulsatile flow and the mock circulatory system can mimic the blood circulation in 
the circulatory system.  
The last two studies were more related to clinical practice. One of these studies is an original research 
study on design and validation of a fast and robust semi-automatic segmentation tool to delineate the 







manually and semi-automatically segmented AVA on 25 CT images. The measurements were then 
compared to the gold standard echocardiography-based results of the same patients. These results 
showed that the developed algorithm provides fast, accurate, and robust way of quantifying AVA. 
Chapter 8 is a systematic review asking the question “Does the aortic annulus undergo conformational 
change throughout the cardiac cycle?”. This is an important question as the aortic annulus size is the 
main metric to determine the size of an implant that will be used in the minimally invasive Trascatheter 
Aortic Valve Implantation (TAVI) procedures. Mistakes made in prosthesis selection may lead to aortic 
regurgitation or rupture of the aortic root. The systematic literature search revealed that the aortic 
annulus was more circular in systole and predominantly oval in diastole. The annular long-axis diameter 
showed insignificant change throughout the cycle, while the short-axis diameter, area, and perimeter 
were significantly larger in systole compared with diastole. These results suggest that the aortic annulus 
goes in to dynamic changes throughout the cardiac cycle and multi-phase aortic annulus measurements 
have utmost importance for TAVI planning in order to prevent under or over sizing of the prosthesis.  
Conclusion 
The non-invasive nature and improved temporal resolution of CT allows exploring new risk factors such 
as vessel geometry to predict the cardiovascular diseases. Moreover, it is the main medical image source 
for 3D printing of physical anatomical models, which can be used in medical training, pre-operative 
planning, and device testing. In addition to the static 3D data, the dynamic 4D CT data provides more 
comprehensive information to prevent under or over sizing of the prosthesis to maximize the outcome of 
the minimally invasive cardiovascular procedures.  
In conclusion, CT is the dominant 3D imaging modality that supports the clinical decision-making at the 
various stages of therapeutic management of cardiovascular diseases from early risk determination to 
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